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A B S T R A C T
Background
Primary postpartum haemorrhage (PPH) is commonly defined as bleeding from the genital tract of 500 mL or more within 24 hours of birth.
It is one of the most common causes of maternal mortality worldwide and causes significant physical and psychological morbidity.
An earlier Cochrane Review considering any treatments for the management of primary PPH, has been split into separate reviews. This
review considers treatment with mechanical and surgical interventions.
Objectives
To determine the eEectiveness and safety of mechanical and surgical interventions used for the treatment of primary PPH.
Search methods
We searched Cochrane Pregnancy and Childbirth’s Trials Register, ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform
(ICTRP) (26 July 2019) and reference lists of retrieved studies.
Selection criteria
Randomised controlled trials (RCTs) of mechanical/surgical methods for the treatment of primary PPH compared with standard care
or another mechanical/surgical method. Interventions could include uterine packing, intrauterine balloon insertion, artery ligation/
embolism, or uterine compression (either with sutures or manually).
We included studies reported in abstract form if there was suEicient information to permit risk of bias assessment. Trials using a cluster-
RCT design were eligible for inclusion, but quasi-RCTs or cross-over studies were not.
Data collection and analysis
Two review authors independently assessed studies for inclusion and risk of bias, independently extracted data and checked data for
accuracy. We used GRADE to assess the certainty of the evidence.
Main results
We included nine small trials (944 women) conducted in Pakistan, Turkey, Thailand, Egypt (four trials), Saudi Arabia, Benin and Mali. Overall,
included trials were at an unclear risk of bias. Due to substantial diEerences between the studies, it was not possible to combine any trials
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in meta-analysis. Many of this review's important outcomes were not reported. GRADE assessments ranged from very low to low, with
the majority of outcome results rated as very low certainty. Downgrading decisions were mainly based on study design limitations and
imprecision; one study was also downgraded for indirectness.
External uterine compression versus normal care (1 trial, 64 women)
Very low-certainty evidence means that we are unclear about the eEect on blood transfusion (risk ratio (RR) 2.33, 95% confidence interval
(CI) 0.66 to 8.23).
Uterine arterial embolisation versus surgical devascularisation plus B-Lynch (1 trial, 23 women)
The available evidence for hysterectomy to control bleeding (RR 0.73, 95% CI 0.15 to 3.57) is unclear due to very low-certainty evidence. The
available evidence for intervention side eEects is also unclear because the evidence was very low certainty (RR 1.09; 95% CI 0.08 to 15.41).
Intrauterine Tamponade
Studies included various methods of intrauterine tamponade: the  commercial  Bakri balloon, a  fluid-filled  condom-loaded latex
catheter ('condom catheter'), an air-filled latex balloon-loaded catheter ('latex balloon catheter'), or traditional packing with gauze.
Balloon tamponade versus normal care (2 trials, 356 women)
One study(116 women) used the condom catheter. This study found that it may increase blood loss of 1000 mL or more (RR 1.52, 95%
CI 1.15 to 2.00; 113 women), very low-certainty evidence. For other outcomes the results are unclear and graded as very low-certainty
evidence: mortality due to bleeding (RR 6.21, 95% CI 0.77 to 49.98); hysterectomy to control bleeding (RR 4.14, 95% CI 0.48 to 35.93);
total blood transfusion (RR 1.49, 95% CI 0.88 to 2.51); and side eEects. A second study of 240 women used the latex balloon catheter
together with cervical cerclage. Very low-certainty evidence means we are unclear about the eEect on hysterectomy (RR 0.14, 95% CI 0.01
to 2.74) and additional surgical interventions to control bleeding (RR 0.20, 95% CI 0.01 to 4.12).
Bakri balloon tamponade versus haemostatic square suturing of the uterus (1 trial, 13 women)
In this small trial there was no mortality due to bleeding, serious maternal morbidity or side eEects of the intervention, and the results are
unclear for blood transfusion (RR 0.57, 95% CI 0.14 to 2.36; very low certainty). Bakri balloon tamponade may reduce mean 'intraoperative'
blood loss (mean diEerence (MD) -426 mL, 95% CI -631.28 to -220.72), very low-certainty evidence.
Comparison of intrauterine tamponade methods (3 trials, 328 women)
One study (66 women) compared the Bakri balloon and the condom catheter, but it was uncertain whether the Bakri balloon reduces the
risk of hysterectomy to control bleeding due to very low-certainty evidence (RR 0.50, 95% CI 0.05 to 5.25). Very low-certainty evidence also
means we are unclear about the results for the risk of blood transfusion (RR 0.97, 95% CI 0.88 to 1.06).
A second study (50 women) compared Bakri balloon, with and without a traction stitch. Very low-certainty evidence means we are unclear
about the results for hysterectomy to control bleeding (RR 0.20, 95% CI 0.01 to 3.97).
A third study (212 women) compared the condom catheter to gauze packing and found that it may reduce fever (RR 0.47, 95% CI 0.38 to
0.59), but again the evidence was very low certainty.
Modified B-Lynch compression suture versus standard B-Lynch compression suture (1 trial, 160 women)
Low-certainty evidence suggests that a modified B-Lynch compression suture may reduce the risk of hysterectomy to control bleeding (RR
0.33, 95% CI 0.11 to 0.99) and postoperative blood loss (MD -244.00 mL, 95% CI -295.25 to -192.75).
Authors' conclusions
There is currently insuEicient evidence from RCTs to determine the relative eEectiveness and safety of mechanical and surgical
interventions for treating primary PPH. High-quality randomised trials are urgently needed, and new emergency consent pathways should
facilitate recruitment.
The finding that intrauterine tamponade may increase total blood loss > 1000 mL suggests that introducing condom-balloon tamponade
into low-resource settings on its own without multi-system quality improvement does not reduce PPH deaths or morbidity. The suggestion
that modified B-Lynch suture may be superior to the original requires further research before the revised technique is adopted. In high-
resource settings, uterine artery embolisation has become popular as the equipment and skills become more widely available. However,
there is little randomised trial evidence regarding eEicacy and this requires further research. We urge new trial authors to adopt PPH core
outcomes to facilitate consistency between primary studies and subsequent meta-analysis.
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P L A I N   L A N G U A G E   S U M M A R Y
Mechanical and surgical interventions for treating women with severe bleeding a?er childbirth
This review considers evidence from randomised controlled trials on using mechanical and surgical interventions for stopping severe
bleeding aFer giving birth. Other Cochrane Reviews consider the use of drugs that promote blood clotting or contractions of the uterus.
What is the issue?
Primary postpartum haemorrhage (PPH) occurs when a mother has excessive vaginal bleeding within 24 hours of giving birth (typically >
500 mL or > 1000 mL). The most common cause of primary PPH is failure of the uterus to contract aFer birth, and usual care is based on
using drugs to reverse this. Other causes include retained placenta, vaginal or cervical tears, and failure of the blood to clot. Surgical and
mechanical methods apply direct pressure on blood vessels to reduce uterine blood flow. Pressure can be applied from inside the uterus
by inflating a balloon within the uterus. Alternatively, pressure can be applied on the outside surface of the uterus. This can be directly
(using a hand), or by passing a stitch through the front and back walls of the uterus to compress the uterine walls together. Blood flow can
also be stopped by tying oE or blocking the blood vessels that feed the uterus.
Why is this important?
PPH is a common cause of maternal death and illness worldwide. Nearly 300,000 pregnant women die annually across the world
with approximately 25% of those deaths caused by haemorrhage. It can also lead to the mother having significant long-term medical and
psychological problems.
What evidence did we find?
We searched for evidence (July 2019) and included nine small randomised controlled trials (944 women). The studies were conducted in
hospital settings in Pakistan, Turkey, Thailand, Egypt (four studies) and Saudi Arabia, and health facilities in Benin and Mali. Overall, the
studies were very diEerent, with various interventions being compared. The small number of women in each study, few or zero events, lack
of data on important outcomes, and wide variation in results meant that few clear findings were obtained. It was not possible to pool the
results from the studies. Our certainty assessments for the trials ranged from low to very low, with the majority rated as very low certainty.
This means that we cannot be confident about the results.
Two studies (356 women) compared internal pressure using non-commercial balloons (a water-filled condom  and a sterilised, air-filled
'party' balloon) and normal care. The condom catheter may result in increased blood loss, but no other important eEects were seen in
either study. A third study found that the condom catheter may reduce postpartum fever compared to packing of the uterus with gauze,
but no other eEects.
Three studies used a commercially available balloon (Bakri). This was compared to external pressure with stitches in one study (13 women)
and it was found that Bakri balloon may reduce blood loss but no other eEects were seen. Another study (66 women) compared the Bakri
balloon to a condom system and found little to no diEerences between groups. The third study (50 women) looked to see if using a stitch
to tether the upper end of the balloon to the top of the uterus had any benefit, but found little to no eEect.
One study (64 women) compared external compression of the uterus with normal care but with no clear findings. Another study of 160
women compared a standard compression suture with a modified version in which the uterus is not only compressed, but the main vessel
supplying the uterus was tied oE. The results suggested that the modified suture may reduce blood loss and the risk of hysterectomy.
One study (23 women) compared using imaging to block the blood vessels to the uterus (uterine artery embolisation) with surgical
techniques to cut oE the blood supply and compress the uterus but found little to no eEect.
What does this mean?
We did not find suEicient high-quality evidence to determine the eEectiveness and safety of mechanical and surgical interventions for
treating primary PPH. High-quality randomised trials are urgently needed to test some of the findings of this review. We urge new trial
authors to adopt standardised PPH core outcomes.
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   External uterine compression (all methods) plus normal care compared to normal care for treating primary postpartum
haemorrhage
External uterine compression (all methods) compared to normal care for treating primary postpartum haemorrhage
Patient or population: women diagnosed with primary PPH following vaginal birth. PPH was defined as quote: "blood loss > 500mL after delivery" p 601
Setting: hospital setting in Bangkok, Thailand (Chantrapitak 2009)
Intervention: external lower uterine compression (either by grasping the uterus through a lax abdominal wall or compressing the uterus against the sacrum and lower ver-
tebrae) for a duration of 10 minutes (plus standard care)
Comparison: normal care alone - consisting of "massage, oxytocin (10-20 units in 1,000 ml of intravenous solution, 200 ml/min), intravenous ergometrine (Methergin®, 0.2



























Mortality due to bleeding - not reported See comment Outcome not reported by trial
authors
Hysterectomy to control bleeding - not reported See comment Outcome not reported by trial
authors
Serious maternal morbidity (renal or respiratory failure, cardiac ar-
rest or multiple organ failure) - not reported
See comment Outcome not reported by trial
authors
Number of women with total blood loss 1000 mL or more after ran-
domisation - not reported
See comment Outcome not reported by trial
authors
Mean blood loss (mL) (trialist defined) See comment Outcome not reported by trial
authors

































































































































































Side effects of the intervention (e.g. trauma, necrosis) - not reported See comment Outcome not reported by trial
authors
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 We downgraded (1) level for serious limitations in study design (risk of bias)
2 We downgraded (2) levels for very serious imprecision due to small sample size, few events and wide confidence interval crossing the line of no eEect
 
 
Summary of findings 2.   One uterine devascularisation technique (uterine arterial embolisation) versus another uterine devascularisation technique
(surgical devascularisation plus B-Lynch)
One uterine devascularisation technique (uterine arterial embolisation) versus another uterine devascularisation technique (surgical devascularisation plus B-
Lynch)
Patient or population: treating primary postpartum haemorrhage
Setting: Ain-Shams University Maternity Hospital, Egypt (Farouk 2016)
Intervention: uterine devascularisation (uterine arterial embolisation)
Comparison: another uterine devascularisation technique (surgical devascularisation plus B-Lynch compression sutures)
Anticipated absolute effects* (95% CI)Outcomes























Mortality due to bleeding - not reported See comment Outcome not reported by
trial authors




























































































































































Serious maternal morbidity (renal or respiratory failure,
cardiac arrest or multiple organ failure)
See comment Outcome not reported by
trial authors
Number of women with total blood loss 1000 mL or
more after randomisation
See comment Outcome not reported by
trial authors
Mean blood loss (mL) (trialist defined) See comment Outcome not reported by
trial authors
Blood transfusion (red cell or whole blood) See comment Outcome not reported by
trial authors
Study populationSide effects of the intervention (e.g. trauma, necrosis)











*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 We downgraded (1) level for serious limitations in study design
2 We downgraded (2) levels for very serious imprecision due to small sample size with few events and wide confidence intervals crossing the line of no eEect
 
 
Summary of findings 3.   Intrauterine balloon tamponade plus normal care (misoprostol) compared to normal care (misoprostol) for treating primary
postpartum haemorrhage
Intrauterine balloon tamponade plus normal care (misoprostol) compared to normal care (misoprostol) for treating primary postpartum haemorrhage
Patient or population: women diagnosed with primary PPH following vaginal birth. Women were suspected to have PPH due to clinical atony and who were quote: "unre-
sponsive to oxytocin and who needed additional uterotonics" p1. PPH was defined as quote: "visual estimation of excessive blood loss and patient status (blood pressure




















































































































































Setting: 7 healthcare facilities in Benin and Mail
Intervention: intrauterine balloon tamponade (plus misoprostol 'standard care')
Comparison: standard care (misoprostol) alone
Anticipated absolute effects* (95% CI)Outcomes
Risk with nor-
mal care
Risk with intrauterine bal-














Study populationMortality due to bleeding







VERY LOW 1 2
 
Study populationHysterectomy to control bleeding







VERY LOW 1 2
 
Serious maternal morbidity (renal or respiratory failure,







Study populationNumber of women with total blood loss 1000 mL or more
after randomisation







VERY LOW 1 3
 






Study populationBlood transfusion (red cell or whole blood)




























































































































































Study populationSide effects of the intervention (e.g. trauma, necrosis) -
Severe shivering, diarrhoea, vomiting or high temperature





VERY LOW 1 5
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 We downgraded (-2) levels for very serious limitations in study design (risk of bias)
2 We downgraded (-2) levels for very serious imprecision due to small sample size, few events and wide confidence interval crossing the line of no eEect
3 We downgraded (-1) level for serious imprecision due to a small sample size
4 We downgraded (-2) levels for very serious imprecision due to small sample size, and wide confidence interval crossing the line of no eEect
5 We downgraded (-2) levels for very serious imprecision due to small sample size and zero events
 
 
Summary of findings 4.   Intrauterine balloon tamponade (latex balloon inflated with air) plus cerclage and normal care compared to normal care for
treating primary postpartum haemorrhage
Intrauterine balloon tamponade (latex balloon inflated with air) plus cerclage and normal care compared to normal care for treating primary postpartum haemor-
rhage
Patient or population: women with PPH, due to atony, following vaginal birth at home or in hospital (Soltan 2007)
Setting: Hospital (Egypt)
Intervention: Latex balloon-loaded Nelson catheter intrauterine tamponade (air filled) plus stitch and standard care (uterine massage and uterotonics)












































































































































































Study populationMortality due to bleeding








There were no maternal deaths due
to bleeding













Serious maternal morbidity (renal or respiratory failure,
cardiac arrest or multiple organ failure)
See comment Outcome not reported by trial au-
thors
Number of women with total blood loss 1000 mL or more
after randomisation
See comment Outcome not reported by trial au-
thors
Mean blood loss (mL) (trialist defined) See comment Outcome not reported by trial au-
thors
Blood transfusion (red cell or whole blood)    
Study populationSide effects of the intervention (e.g. trauma, necrosis) -









There were no side effects of the
intervention (reported as trauma,
pyrexia, or allergic reaction)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 We downgraded (-1) level for serious limitations in study design (risk of bias)
2 We downgraded (-2) levels for very serious indirectness (the study population included all women with PPH (UBT used as a first-line treatment), rather than only those who
did not respond to treatment with uterotonics
3 We downgraded (-2) levels for very serious imprecision (small sample size, no events, not estimable)























































































































































Summary of findings 5.   Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (intrauterine tamponade
versus another mechanical/surgical method) for treating primary postpartum haemorrhage
Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (intrauterine tamponade versus another mechanical/surgical
method) for treating primary postpartum haemorrhage
Patient or population: women with complete placenta praevia and intractable bleeding following caesarean section
Setting: university hospital setting in Turkey (Kavak 2013)
Intervention: intrauterine tamponade (Bakri balloon)
Comparison: endouterine compression suturing to the lower segment of the uterus
Anticipated absolute effects* (95% CI)Outcomes



















Study populationMortality due to bleeding











Study populationHysterectomy to control bleeding











Study populationSerious maternal morbidity (renal or res-
piratory failure, cardiac arrest or multiple











Number of women with total blood loss





Mean blood loss (mL) (trialist defined) The mean blood loss in end-
outerine compression suture
group was 1946 mL
The mean difference in blood loss
(mL) in the intervention group was




























































































































































Study populationBlood transfusion (red cell or whole
blood)








VERY LOW 1 4
 
Study populationSide effects of the intervention (e.g. trau-
ma, necrosis)







VERY LOW 1 2
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 We downgraded (2) levels for very serious limitations in study design (risk of bias)
2 We downgraded (2) levels for very serious imprecision due to small sample size and zero events (not estimable)
3 We downgraded (1) level for serious imprecision due to a small sample size (continuous data)
4 We downgraded (2) levels for very serious imprecision due to small sample size, few events and wide confidence interval crossing the line of no eEect
 
 
Summary of findings 6.   Bakri balloon tamponade versus condom-loaded Foley Catheter (one intrauterine tamponade compared to another
intrauterine tamponade technique) for treating primary postpartum haemorrhage
Bakri balloon tamponade versus condom-loaded Foley Catheter (one intrauterine tamponade compared to another intrauterine tamponade technique for treating
primary postpartum haemorrhage)
Patient or population: women with primary atonic postpartum haemorrhage following vaginal delivery
Setting: Assuit Women's Health Hospital in Egypt (Darwish 2018)
Intervention: 1 intrauterine tamponade: Bakri balloon
Comparison: another intrauterine tamponade technique: condom-loaded Foley catheter












































































































































































Mortality due to bleeding See comment Outcome not reported by trial authors
Study populationHysterectomy to control bleeding











Serious maternal morbidity (renal or respiratory
failure, cardiac arrest or multiple organ failure)
See comment Outcome not reported by trial authors
Number of women with total blood loss 1000 mL
or more after randomisation
See comment Outcome not reported by trial authors
Mean blood loss (mL) (trialist defined) See comment Outcome not reported by trial authors













Note: the trial report states that analysis for this
and other trial secondary outcomes excluded
those women in whom there was treatment
failure.
Side effects of the intervention (e.g. trauma,
necrosis)
See comment Outcome not reported by trial authors
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 We downgraded (1) level for serious limitations in study design (risk of bias)
2 We downgraded (2) levels for very serious imprecision (small sample size, few events, and wide confidence interval including appreciable benefit and appreciable harm)





















































































































































4 We downgraded (2) levels for very serious limitations in study design (post-randomisation exclusions - analysis excluded those women in whom there was treatment failure)
 
 
Summary of findings 7.   Bakri balloon tamponade+traction stitch versus Bakri balloon (one intrauterine tamponade compared to another
intrauterine tamponade technique) for treating primary postpartum haemorrhage)
Bakri balloon tamponade+traction stitch versus Bakri balloon (one intrauterine tamponade compared to another intrauterine tamponade technique) for treating
primary postpartum haemorrhage
Patient or population: women with primary atonic postpartum haemorrhage
Setting: a security forces hospital in Riyadh, Saudi Arabia (Khalil 2011)
Intervention: intrauterine tamponade: Bakri balloon with traction stitch
Comparison: another intrauterine tamponade technique: Bakri balloon without traction stitch


























Mortality due to bleeding See comment Outcome not reported by trial
authors
Study populationHysterectomy to control bleeding











Serious maternal morbidity (renal or respiratory failure, car-
diac arrest or multiple organ failure)
See comment Outcome not reported by trial
authors
Number of women with total blood loss 1000 mL or more af-
ter randomisation
See comment Outcome not reported by trial
authors
Mean blood loss (mL) (trialist defined) See comment Outcome not reported by trial
authors






















































































































































Side effects of the intervention (e.g. trauma, necrosis) See comment Outcome not reported by trial
authors
Study populationTotal blood loss >= 1000 mL (before and after randomisation,
outcome not pre-specified in our protocol)










*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 We downgraded (1) level for serious limitations in study design (risk of bias)
2 We downgraded (2) levels for very serious imprecision due to small sample sizes, few events and wide confidence interval crossing the line of no eEect
3 We downgraded (1) level for serious imprecision due to small sample size
 
 
Summary of findings 8.   Intrauterine balloon tamponade (condom-loaded catheter) versus uterovaginal packing (intrauterine tamponade versus
another intrauterine tamponade method) for treating primary postpartum haemorrhage
Intrauterine balloon tamponade (condom-loaded catheter) versus uterovaginal packing (intrauterine tamponade versus another intrauterine tamponade
method) for treating primary postpartum haemorrhage
Patient or population: Women (aged between 20 and 40) diagnosed with primary PPH following 'normal' vaginal birth and unresponsive to medical treatment (Ashraf
2018)
Setting: Hospital setting in Pakistan


















































































































































































Mortality due to bleeding See comment Outcome not reported by trial authors
Hysterectomy to control bleeding See comment Outcome not reported by trial authors
Serious maternal morbidity (renal or res-
piratory failure, cardiac arrest or multiple
organ failure)
See comment Outcome not reported by trial authors
Number of women with total blood loss
1000 mL or more after randomisation
See comment Outcome not reported by trial authors
Mean blood loss (mL) (trialist defined) See comment Mean blood loss is reported as 600.28 mL (+/- 25.33 mL) in the
condom catheter group and 699 mL (+/- 70.176 mL) in the in-
trauterine packing group. However, it is unclear whether this
is pre- or post-randomisation, especially as this is also present-
ed in a table detailing participant characteristics of each group
(age, parity, gestational age, and blood loss). For this reason,
we have not included these data in our data and analysis ta-
bles.
Blood transfusion (red cell or whole
blood)
See comment Outcome not reported by trial authors
Study populationSide effects of the intervention (e.g. trau-
















*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.





















































































































































Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 We downgraded (2) levels for very serious limitations in study design (risk of bias)
2 We downgraded (1) level for serious imprecision (small sample size)
 
 
Summary of findings 9.   Modified B-Lynch compression suture technique versus standard B-Lynch compression suture (one uterine compression
suture technique versus another uterine compression suture technique) for treating primary postpartum haemorrhage
Modified B-Lynch compression suture technique versus standard B-Lynch compression suture (one uterine compression suture technique versus another uterine
compression suture technique) for treating primary postpartum haemorrhage
Patient or population: women with uncontrolled atonic PPH following caesarean section, and not responding to standard care (uterine massage, ecbolics and bimanual
compression).
Setting: university hospital in Cairo, Egypt (El-Sokkary 2016)
Intervention: 1 uterine compression suture technique: modified B-Lynch compression suture
Comparison: another uterine compression suture technique: standard B-Lynch compression suture






















Mortality due to bleeding See comment Outcome not reported
by trial authors
Study populationHysterectomy to control bleeding










Serious maternal morbidity (renal or respirato-
ry failure, cardiac arrest or multiple organ fail-
ure)
See comment Outcome not reported
by trial authors
Number of women with total blood loss 1000
mL or more after randomisation
See comment Outcome not reported
by trial authors
Mean blood loss (mL) (trialist defined) The mean blood loss
in the classic B-Lynch
group was 568 mL
The mean difference in blood
loss (mL) in the modified B-
























































































































































(295.25 mL lower to - 192.75 mL
lower)
Blood transfusion (red cell or whole blood)   Outcome not reported
by trial authors
Side effects of the intervention (e.g. trauma,
necrosis)
See comment Outcome not reported
by trial authors
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio.
GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.
1 We downgraded (1) level for serious limitations in study design (risk of bias)
2 We downgraded (1) level for serious imprecision due to small sample size and few events
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B A C K G R O U N D
An earlier Cochrane Review (Mousa 2014c) considered various
treatments for the management of primary postpartum
haemorrhage (PPH). That review has now been split, with diEerent
treatment types considered in separate reviews.
• Antifibrinolytic agents for treating primary PPH is covered by
Shakur 2018.
• Mechanical and surgical interventions are considered in this
review.
• Uterotonic agents for treating primary PPH are covered by a
new review on First-line uterotonics for treating postpartum
haemorrhage: a systematic review and network meta-analysis
(Parry Smith 2017).
Description of the condition
Primary PPH is defined as bleeding from the genital tract of 500
mL or more in the first 24 hours following delivery of the baby
(WHO 2012; WHO 2015) and severe PPH is defined as blood loss
more than 1000 mL, regardless of the route of delivery (Hoveyda
2001; Sentilhes 2016). Secondary PPH occurs when women have
abnormal or heavy vaginal bleeding between 24 hours and 12
weeks aFer the birth and it aEects fewer than two in 100 women
(WHO 2012).
Primary PPH, with a global prevalence rate of about 6%, is one
of the most common causes of maternal morbidity and mortality
worldwide (Carroli 2008). Nearly 300,000 women die annually
across the world from causes related to pregnancy and childbirth
(Alkema 2016; Lozano 2011), and approximately a quarter of these
are due to primary PPH (WHO 2012). In high-income countries
there is an increasing rate of primary PPH (Knight 2009). In the
Netherlands there was an increase from 4.1% in 2000 to 6.4% by
2013 (van Stralen 2016). Similar trends have been reported in the
United States of America with a rise from 1.9% in 1999 to 4.2%
in 2008 (Kramer 2013). In sub-Saharan Africa the rate of primary
PPH is reported as high at 10.5% (Carroli 2008). In the low- and
middle-income countries, primary PPH remains the leading cause
of maternal death, accounting for one-third of maternal deaths in
Asia and Africa (Carroli 2008; Kassebaum 2014; Khan 2006).
Major primary PPH can lead to significant maternal morbidity
including shock, renal failure, respiratory failure and/or liver failure
(Bonnar 2000). Severe PPH can cause ischaemic pituitary necrosis
(Sheehan’s syndrome) which can be life-threatening (Matsuzaki
2017). Furthermore, PPH may have a long-term psychological
impact on women's health in the form of negative memories of
childbirth and postpartum period with the main fear being of death
(Sentilhes 2011a).
Visual assessment of blood loss is the most frequently used
method of determining blood loss following childbirth (Hancock
2015). Unfortunately, this method oFen under-estimates blood
loss. Compared to measured blood loss following delivery, visual
(clinical) assessment underestimates blood loss by 100 mL to 150
mL (Kerr 2016; Sloan 2010). For accurate measurement of blood
loss, many clinicians use a combination of direct measurement and
gravimetric methods.
Causes and risk factors
Uterine atony is considered the most common cause of primary
PPH. Other aetiological factors include retained parts of the
placenta, vaginal or cervical tears, and coagulation failure. Uterine
rupture and uterine inversion are extremely rare but, when they
occur, could result in heavy bleeding (WHO 2015). Investigators
have identified risk factors for PPH as first pregnancy (Gilbert 1987),
maternal obesity (Aisaka 1988), a large baby (Stones 1993), twin
pregnancy (Combs 1991; Suzuki 2012), prolonged or augmented
labour (Gilbert 1987), chorioamnionitis, pre-eclampsia, maternal
anaemia and placenta praevia and abruptio placenta (antepartum
haemorrhage) (Kramer 2011; Wetta 2013). The largest bleeds occur
usually in women with retained placenta, emergency caesarean
section, and placental abruption and praevia (Green 2016).
However women with no potential risk factors oFen unpredictably
develop primary PPH (Mousa 2008; Weeks 2015a).
The morbidity and mortality due to PPH in low-income countries
is aggravated by poor nutritional status, lack of easy access to
treatment, inadequate intensive care and blood bank services (El
Ayadi 2013; Khan 2006).
Treatment approaches
Treatment for primary PPH requires a multidisciplinary team
approach. The treatment involves resuscitation to manage
obstetric haemorrhage, identification of the causes, and
management. AFer exclusion of lower genital tract tears and
coagulopathy, uterine atony is managed by using uterotonics that
increase the eEiciency of uterine contraction, and tranexamic
acid to promote coagulation (WOMAN 2017). If uterine bleeding is
ongoing despite these interventions, the use of haemostatic drugs
with mechanical methods to compress the uterus is advisable.
Several mechanical methods have been described to control the
bleeding and these are described below under Description of the
intervention.
The non-pneumatic anti-shock garment (NASG) has also been used
in the management of primary PPH. It is used before transport of
patients with shock due to primary PPH to stabilise them for referral
to higher level hospitals (Miller 2013b). This technique will be the
focus of another Cochrane Review.
Hysterectomy works by ligating the blood vessels to the uterus
and removing the uterus which is the bleeding site. Peripartum
hysterectomy is a major operation and is performed only in the
event of life threatening haemorrhage during or immediately
aFer abdominal or vaginal deliveries when all other options
have been exhausted (Machado 2011). Indeed, the first caesarean
hysterectomy ever described was conducted in order to prevent
death from uterine haemorrhage (Porro 1876). In this review it is
included as an outcome rather than an intervention, as it is the last
resort to control intractable bleeding, and is therefore unlikely to
be ever be an intervention tested in a randomised trial.
The choice of the type of mechanical intervention depends on
several factors and, in particular, the experience of the surgeon.
Other relevant published Cochrane Reviews on management
of PPH are Mousa 2014c which evaluated the comprehensive
treatment of PPH, Begley 2019, which compares active with
expectant third-stage management; Liabsuetrakul 2018; McDonald
2004; Pantoja 2016; Tunçalp 2012 and Oladapo 2018, which
Mechanical and surgical interventions for treating primary postpartum haemorrhage (Review)
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considered the role of diEerent prophylactic uterotonics in
third-stage management; Abdel-Aleem 2015, Grillo-Ardila 2014;
Mori 2012, which examined the treatment of retained placenta;
Oladapo 2012, which evaluated advance community distribution of
misoprostol for preventing or treating PPH; Novikova 2015a, Shakur
2018, which evaluated the place of tranexamic acid for preventing
PPH, and Alexander 2002, which examined drug treatment for
secondary PPH. Other Cochrane Reviews have looked at the use
of uterine massage (Hofmeyr 2013b) and breastfeeding or nipple
stimulation (Abedi 2016) for preventing PPH.
Description of the intervention
In the event of failure of the uterotonics, PPH management turns
to mechanical and surgical methods (WHO 2012). Whilst this review
will consider mechanical and surgical methods, there is no clear
distinction between the two approaches. Both approaches act
through direct pressure on the placental bed, by reducing uterine
blood flow through external pressure on the uterus, or through the
interruption of vascular flow to the uterus.
Direct pressure on the placental bed can be achieved by internal
balloon tamponade using the Sengstaken-Blakemore tube (Chan
1997), the Rusch catheter (Johanson 2001), the Bakri balloon (Bakri
2001), or by packing the uterine cavity with several metres of gauze
(Eastman 1950). The overall success rate for packing is reported to
be around 80% (Doumouchtsis 2007; Georgiou 2009).
External pressure on the uterus can be achieved with uterine
compression sutures (B-Lynch 1997; Marasinghe 2011; Zheng 2011).
B-Lynch was the first to describe a suture that runs through the
full thickness of both uterine walls (anterior and posterior; B-Lynch
1997). When tied, the suture allows tight compression of the uterine
walls and stops the bleeding (Mousa 2001). The modifications of
this include the simple brace suture (Hayman 2002) or square
sutures (Cho 2000). Uterine compression sutures have been found
to be eEective in stopping uterine bleeding (Cekmez 2015a), but
complications of intrauterine synechiae (Poujade 2011; Rathat
2011) and/or infection (Ochoa 2002) can occur.
Vascular flow to the uterus can be interrupted by uterine
devascularisation, ligation of the uterine or internal iliac arteries,
embolisation or aortic compression. These are considered in
selected cases where bleeding is persistent (Cekmez 2015a;
Jouppila 1995). The success rate of devascularisation appears to be
less than 50% (Clark 1985). A simple way of achieving temporary
uterine devascularisation is through compression of the aorta.
This techniquemay be especially useful for PPH with a retained
placenta.
How the intervention might work
Compression of the aorta through the abdomen is an emergency
manoeuvre proposed to reduce PPH and permit time for
resuscitation and control of bleeding. This technique involves
compression of the aorta by placing a fist or the heel of the hand
onto the aorta through the lax postnatal abdominal wall. The
femoral pulse is checked to ensure occlusion, and the compression
can be maintained for up to 90 minutes (Pereira 2005). This cuts oE
the blood supply to the uterus and hence reduces uterine bleeding.
The packing of the uterus with gauze or Sengstaken-Blakemore
tube or the Rusch catheter balloon applies pressure on the
placental site and this reduces uterine bleeding (Georgiou 2009).
The devascularisation or ligation of uterine blood vessels and/or
occasionally internal iliac arteries that supply blood to the uterus
cuts oE the blood supply to the uterus and stops uterine bleeding
(Cekmez 2015a). The B-Lynch suture reinforces the contraction of
the uterus by keeping the uterus contracted, thus reducing uterine
bleeding (Cekmez 2015a; Mousa 2001). The Bakri balloon stops the
bleeding by exerting pressure at the placental site (Cekmez 2015a).
Why it is important to do this review
This review is dedicated to assessing the eEectiveness and safety
of mechanical and surgical methods for the treatment of primary
PPH and aims to inform local and national practices and guide
clinicians and midwives on their role when managing PPH.
Whilst first-line treatment is usually pragmatic, using uterotonics,
ongoing bleeding is managed with a combination of uterotonics,
mechanical and surgical methods depending on the underlying
cause of the bleeding (WHO 2012). These can be used successively
or in combination. Much of our current practice is based on expert
opinion as randomised trials in this area are diEicult to carry out
(Weeks 2015a).
An earlier Cochrane Review (Mousa 2014c), considered all of the
various treatment modalities for the management of primary
PPH; the review has now been split in order to facilitate a more
detailed analysis of diEerent types of interventions. The use of
antifibrinolytic drugs for treating primary PPH is covered in a recent
new Cochrane review (Shakur 2018). In contrast, our review will
focus on the use of mechanical and surgical interventions for
treating primary PPH. The topic of uterotonic agents for treating
primary PPH will be covered by another review.
O B J E C T I V E S
To determine the eEectiveness and safety of mechanical
and surgical interventions used for the treatment of primary
postpartum haemorrhage.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) of mechanical and surgical
management of postpartum haemorrhage (PPH). In future updates
of this review, if identified, trials using a cluster-RCT design will be
included, and studies reported as abstracts will only be included if
there is suEicient information to allow assessment of risk bias.
Quasi-RCTs or cross-over studies are not eligible for inclusion in this
review.
Types of participants
Women aFer delivery following a pregnancy of at least 24 weeks’
gestation with a diagnosis of primary PPH, regardless of mode of
delivery (vaginal or caesarean section) or other aspects of third-
stage management.
We did not include trials of 'all' women that also happened to
include women with  PPH. We  also did not include trials of all
women including those with PPH (where the trial authors did not
provide subgrouped results for women with PPH).
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Obtaining a blood loss measurement can be diEicult, therefore
trials may have diEerent ways of defining PPH:
• women with blood loss of 500 mL or more; and/or
• women with primary PPH requiring blood transfusion and/or
blood products; and/or
• women with a clinical diagnosis of primary PPH (as defined by
the trialists).
Exclusion criteria
• Women with PPH with gestational age less than 24 weeks.
• Women with heavy vaginal bleeding aFer 24 hours of birth
(secondary PPH).
Types of interventions
Mechanical or surgical interventions such as uterine packing or
intrauterine balloon insertion, artery ligation, uterine compression
(sutures or manually).
We compared one mechanical/surgical method (or a combined
methods) versus standard care or another mechanical/surgical
method, or combined methods.
For example, the following interventions were eligible.
1. External uterine compression (all methods) versus normal care
2. External uterine compression (all methods) versus another
mechanical/surgical method
3. One external uterine compression technique verus another
external uterine compression technique
4. Uterine devascularisation (all methods) versus normal care
5. Uterine devascularisation (all methods) versus another
mechanical/surgical method
6. One uterine devascularisation versus another uterine
devascularisation technique
7. Intrauterine tamponade (all methods) versus normal care
8. Intrauterine tamponade (all methods) versus another
mechanical/surgical method
9. One intrauterine tamponade versus another intrauterine
tamponade technique
10.Uterine compression sutures (all methods) versus normal care
11.Uterine compression sutures (all methods) versus another
mechanical/surgical method
12.One uterine compression suture technique versus another
uterine compression suture technique
Use of non-pneumatic antishock garment, or arterial embolisation
were not considered in this review.
We present results stratified by the type of mechanical or surgical
method.
Types of outcome measures
Types of outcome measures are shown below.
Primary outcomes
1. Mortality due to bleeding
2. Hysterectomy to control bleeding
3. Serious maternal morbidity (renal or respiratory failure, cardiac
arrest or multiple organ failure)
Secondary outcomes
1. All-cause mortality*
2. Mortality from causes other than bleeding
3. Shock as defined by trialist*
4. Coagulopathy as defined by trialist*
5. Number of women with total blood loss 500 mL or more aFer
randomisation*
6. Number of women with total blood loss 1000 mL or more aFer
randomisation*
7. Mean blood loss (mL) (trialist defined)*
8. Blood transfusion (red cell or whole blood)*
9. Blood product transfusion*
10.Post-randomisation additional uterotonic agent used to control
bleeding*
11.Post-randomisation additional surgical interventions used to
control bleeding (arterial ligation, compressive, uterine sutures,
arterial embolisation, laparotomy)*
12.Post-randomisation additional non-surgical intervention to
control bleeding (uterine packing, bimanual uterine massage,
tamponade, external aortic compression and compression
garments)
13.Admission to higher level of care*
14.Side eEects of the intervention (e.g. trauma, necrosis)
15.Days in hospital
16.Breastfeeding (defined as any breastfeeding at hospital
discharge)*
17.Maternal satisfaction with therapy (trialist defined)*
18.Quality of life, including physiological activity and social and
emotional changes (sense of well-being) (trialist defined)*
*outcomes form part of a core outcome set that will be used in all
PPH reviews.
NOTE: we anticipated that assessment of blood loss could vary
between trials. We considered that measurement of blood and
blood clots in jars and weighing of linen are likely to be more precise
than clinical judgement. The latter is known to underestimate
blood loss. The way of reporting the amount of loss as ’greater than’
or ’greater than or equal to’ a certain cut-oE level (e.g. greater than
500 mL or greater than or equal to 500 mL) may aEect the total
reported amount of blood loss.
Search methods for identification of studies
The following methods section of this protocol is based on a
standard template used by Cochrane Pregnancy and Childbirth.
Electronic searches
We searched Cochrane Pregnancy and Childbirth’s Trials Register
by contacting their Information Specialist (26 July 2019).
The Register is a database containing over 25,000 reports of
controlled trials in the field of pregnancy and childbirth. It
represents over 30 years of searching. For full current search
methods used to populate Pregnancy and Childbirth’s Trials
Register including the detailed search strategies for CENTRAL,
Mechanical and surgical interventions for treating primary postpartum haemorrhage (Review)
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MEDLINE, Embase and CINAHL; the list of handsearched journals
and conference proceedings, and the list of journals reviewed via
the current awareness service, please follow this link
Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by their Information Specialist and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of Controlled
Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals plus
monthly BioMed Central email alerts.
Search results are screened by two people and the full text of
all relevant trial reports identified through the searching activities
described above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a
specific Pregnancy and Childbirth review topic (or topics), and is
then added to the Register. The Information Specialist searches
the Register for each review using this topic number rather than
keywords. This results in a more specific search set that has
been fully accounted for in the relevant review sections (Included
studies; Excluded studies; Ongoing studies).
In addition, we searched ClinicalTrials.gov and the WHO
International Clinical Trials Registry Platform (ICTRP) for
unpublished, planned and ongoing trial reports (26 July 2019) using
the methods detailed in Appendix 1.
Searching other resources
We searched the reference lists of retrieved studies.
We did not apply any language or date restrictions.
Data collection and analysis
The following methods section of this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
Selection of studies
Three review authors (AW/FK/JW) independently assessed for
inclusion all the potential studies we identified as a result of the
search strategy. We resolved any disagreement through discussion
and had no need to consult with the other member of the review
team.
We created a study flow diagram to map out the number of records
identified, included and excluded.
Data extraction and management
We designed a form to extract data. Extracted data included trial
dates, sources of trial funding and trial authors' declarations of
interest. For eligible studies, at least two review authors extracted
the data using the agreed form. We resolved discrepancies through
discussion or, where required, we consulted with a third member
of the review team. We entered data into Review Manager soFware
(RevMan 2014) and checked them for accuracy. When information
regarding any of the above is unclear, we attempted to contact
authors of the original reports to provide further details; where we
contacted trial authors, information is listed in Characteristics of
included studies.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We resolved any
disagreement by discussion or by involving a third assessor.
(1) Random sequence generation (checking for possible
selection bias)
We describe for each included study the method used to generate
the allocation sequence in suEicient detail to allow an assessment
of whether it should produce comparable groups.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random number
table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even date
of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection bias)
We describe for each included study the method used to conceal
allocation to interventions prior to assignment and assessed
whether intervention allocation could have been foreseen in
advance of, or during recruitment, or changed aFer assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
We describe for each included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies are
at low risk of bias if they were blinded, or if we judged that the lack
of blinding would be unlikely to aEect results. We assessed blinding
separately for diEerent outcomes or classes of outcomes.
We assessed the methods as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We describe for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for diEerent
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
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• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
We describe for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition
and exclusions from the analysis. We state whether attrition and
exclusions were reported and the numbers included in the analysis
at each stage (compared with the total randomised participants),
reasons for attrition or exclusion where reported, and whether
missing data were balanced across groups or were related to
outcomes. Where suEicient information was reported, or could be
supplied by the trial authors, we re-included missing data in the
analyses which we undertook.
We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing outcome
data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing
data imbalanced across groups; ‘as treated’ analysis done
with substantial departure of intervention received from that
assigned at randomisation);
• unclear risk of bias.
(5) Selective reporting (checking for reporting bias)
We describe for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it is clear that all of the study’s pre-
specified outcomes and all expected outcomes of interest to the
review have been reported);
• high risk of bias (where not all the study’s pre-specified
outcomes have been reported; one or more reported primary
outcomes were not pre-specified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
(6) Other bias (checking for bias due to problems not covered by
(1) to (5) above)
We describe for each included study any important concerns we
have about other possible sources of bias.
We assessed whether each study was free of other problems that
could put it at risk of bias:
• low risk of other bias;
• high risk of other bias;
• unclear whether there is risk of other bias.
(7) Overall risk of bias
We made explicit judgements about whether studies are at high
risk of bias, according to the criteria given in the Handbook (Higgins
2011). With reference to (1) to (6) above, we assessed the likely
magnitude and direction of the bias and whether we considered it
likely to impact on the findings. We planned to explore the impact
of the level of bias through undertaking sensitivity analyses - see
Sensitivity analysis.
Measures of treatment eBect
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% confidence intervals.
Continuous data
For continuous data, we used the mean diEerence if outcomes are
measured in the same way between trials. In future updates, we
will use the standardised mean diEerence to combine trials that
measure the same outcome, but use diEerent methods.
Unit of analysis issues
Cluster-randomised trials
We did not identify any cluster-RCTs for inclusion in this review.
In future updates, if we identify any cluster-RCTs we will include
them in our analyses along with individually-randomised trials.
We will adjust their sample sizes using the methods described
in the Handbook [Section 16.3.4 or 16.3.6] using an estimate of
the intracluster correlation co-eEicient (ICC) derived from the trial
(if possible), from a similar trial, or from a study of a similar
population. If we use ICCs from other sources, we will report
this and conduct sensitivity analyses to investigate the eEect
of variation in the ICC. If we identify both cluster-randomised
trials and individually-randomised trials, we plan to synthesise the
relevant information. We will consider it reasonable to combine the
results from both if there is little heterogeneity between the study
designs and the interaction between the eEect of intervention and
the choice of randomisation unit is considered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform a sensitivity analysis to investigate the eEects of the
randomisation unit.
Cross-over trials
A cross-over trial is not a valid methodology for trials of PPH as it is
an acute emergency.
Dealing with missing data
For included studies, we noted levels of attrition. In future updates,
if appropriate, we will explore the impact of including studies with
high levels of missing data in the overall assessment of treatment
eEect by using sensitivity analysis.
For all outcomes, we carried out our analyses, as far as possible,
on an intention-to-treat basis, i.e. we attempted to include all
participants randomised to each group in the analyses, and all
participants were analysed in the group to which they were
allocated, regardless of whether or not they received the allocated
intervention. The denominator for each outcome in each trial is the
number randomised minus any participants whose outcomes are
known to be missing.
Assessment of heterogeneity
In future updates, we will assess statistical heterogeneity in each
meta-analysis using the Tau2, I2 and Chi2 statistics. We will regard
heterogeneity as substantial if the I2 is greater than 30% and either
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the Tau2 is greater than zero, or if there is a low P value (less than
0.10) in the Chi2 test for heterogeneity.
Assessment of reporting biases
In future updates, if there are 10 or more studies in the meta-
analysis we will investigate reporting biases (such as publication
bias) using funnel plots. We will assess funnel plot asymmetry
visually. If asymmetry is suggested by a visual assessment, we will
perform exploratory analyses to investigate it.
Data synthesis
We did not combine data in meta-analysis due to clinical
heterogeneity. In future updates, is appropriate, we will carry out
statistical analysis using the Review Manager soFware (RevMan
2014). We will use fixed-eEect meta-analysis for combining data
where it is reasonable to assume that studies are estimating the
same underlying treatment eEect: i.e. where trials are examining
the same intervention, and the trials’ populations and methods
are judged suEiciently similar. If there is clinical heterogeneity
suEicient to expect that the underlying treatment eEects diEer
between trials, or if substantial statistical heterogeneity is detected,
we will use random-eEects meta-analysis to produce an overall
summary, if an average treatment eEect across trials is considered
clinically meaningful. The random-eEects summary will be treated
as the average of the range of possible treatment eEects and we
will discuss the clinical implications of treatment eEects diEering
between trials. If the average treatment eEect is not clinically
meaningful, we will not combine trials.
If we use random-eEects analyses, the results will be presented as
the average treatment eEect with 95% confidence intervals, and the
estimates of Tau2 and I2.
Subgroup analysis and investigation of heterogeneity
In future updates, if we identify substantial heterogeneity, we will
investigate it using subgroup analyses. We will consider whether
an overall summary is meaningful, and if it is, use random-eEects
analysis to produce it.
Our planned subgroup analysis:
• placenta praevia versus no placenta praevia;
• mode of delivery (caesarean section versus vaginal birth)
Subgroup analysis will be restricted to the review’s primary
outcomes.
We will assess subgroup diEerences by interaction tests available
within RevMan (RevMan 2014). We will report the results of
subgroup analyses quoting the Chi2 statistic and P value, and the
interaction test I2 value.
Sensitivity analysis
In future updates, if appropriate, we will undertake sensitivity
analyses to explore the eEect of risk of bias by temporarily
excluding trials at high or unclear risk of bias (for selection bias
or attrition bias) to see if it makes a diEerence in the overall
result. We will also carry out sensitivity analysis to explore the
impact of including studies with high levels of missing data in
the overall assessment of treatment eEect. We will also carry out
sensitivity analysis to investigate the eEect of the randomisation
unit where we combine cluster-RCTs and individually-randomised
trials in meta-analysis. Sensitivity analysis will only be performed
for the review's primary outcomes.
Summary of findings and assessment of the certainty of the
evidence
The certainty of the evidence was assessed using the GRADE
approach as outlined in the GRADE handbook in order to assess the
certainty of the body of evidence relating to the following outcomes
for the main comparisons.
• External uterine compression (all methods) versus normal care
• External uterine compression (all methods) versus another
surgical/mechanical method
• One external uterine compression technique verus another
external uterine compression technique
• Uterine devascularisation (all methods) versus normal care
• Uterine devascularisation (all methods) versus another surgical/
mechanical method
• One uterine devascularisation versus another uterine
devascularisation technique
• Intrauterine tamponade (all methods) versus normal care
• Intrauterine tamponade (all methods) versus another surgical/
mechanical method
• One intrauterine tamponade versus another intrauterine
tamponade technique
• Uterine compression sutures (all methods) versus normal care
• Uterine compression sutures (all methods) versus another
mechanical or surgical method
• One uterine compression suture technique versus another
uterine compression suture technique
We assessed the following outcomes.
1. Mortality due to bleeding
2. Hysterectomy to control bleeding
3. Serious maternal morbidity (renal or respiratory failure, cardiac
arrest or multiple organ failure
4. Number of women with total blood loss 1000 mL or more aFer
randomisation*
5. Mean blood loss (mL) (trialist defined)*
6. Blood transfusion (red cell or whole blood)*
7. Side eEects of the intervention (e.g. trauma, necrosis)
We used the GRADEpro Guideline Development Tool to import
data from Review Manager 5.3 (RevMan 2014) in order to create
’Summary of findings’ tables. A summary of the intervention
eEect and a measure of quality for each of the above outcomes
was produced using the GRADE approach. The GRADE approach
uses five considerations (study limitations, consistency of eEect,
imprecision, indirectness and publication bias) to assess the
quality of the body of evidence for each outcome. The evidence can
be downgraded from 'high certainty' by one level for serious (or by
two levels for very serious) limitations, depending on assessments
for risk of bias, indirectness of evidence, serious inconsistency,
imprecision of eEect estimates or potential publication bias.
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R E S U L T S
Description of studies
Studies contained within this review are described below.
Results of the search
See: Figure 1
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Figure 1.   Study flow diagram.
 
We retrieved 35 study reports to assess. In addition, we identified
two further trials (Soltan 2007; Ashraf 2018) from correspondence.
We included nine trials (12 trial reports), excluded 17 trials, and
six trials are ongoing (see Characteristics of ongoing studies).
There are also two trials listed in Characteristics of studies
awaiting classification - these trials are listed in trials registries
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as 'completed' and we have contacted the authors for more
information about whether the results are currently available.
Included studies
We included nine trials (involving a total of 944 women) (Ashraf
2018; Chantrapitak 2009; Darwish 2018; Dumont 2017; El-Sokkary
2016; Farouk 2016; Kavak 2013; Khalil 2011; Soltan 2007).
Methods, trial dates and settings
Methods
Ashraf 2018, Chantrapitak 2009, Darwish 2018, El-Sokkary 2016,
Farouk 2016, Kavak 2013, Khalil 2011 and Soltan 2007 were
randomised controlled trials (RCTs). Dumont 2017, was a multi-
centre RCT. Sample sizes ranged between 13 (Kavak 2013) and 240
(Soltan 2007).
Trial dates
The trials were conducted between 2003 and 2015:
• the Ashraf 2018 trial report does not provide the study dates but
states the study took place over one year;
• Soltan 2007 2003 to 2004;
• Khalil 2011 April 2004 until April 2009;
• January to August 2008 Chantrapitak 2009;
• Farouk 2016 May 2011 until May 2013;
• August 2011 to August 2012 Kavak 2013;
• January 2013 to October 2015 El-Sokkary 2016;
• May 2013 to December 2015 Dumont 2017;
• Darwish 2018 October 2014 until December 2015.
Settings
Settings included a university hospital setting in Pakistan
(Ashraf 2018), Turkey (Kavak 2013), hospital settings in Thailand
(Chantrapitak 2009), Egypt (Darwish 2018; El-Sokkary 2016; Farouk
2016; Soltan 2007), a security forces hospital in Saudi Arabia (Khalil
2011), and healthcare facilities in Benin and Mali (Dumont 2017).
Participants
All of the women in the included studies were reported as having
primary postpartum haemorrhage (PPH). In five of the studies,
PPH was due to uterine atony (Darwish 2018; Soltan 2007) or
suspected uterine atony (Dumont 2017) following vaginal birth or
either vaginal birth or and caesarean in Farouk 2016. Women in the
Chantrapitak 2009 and Ashraf 2018 studies had a vaginal birth, but
the precise cause of PPH was not reported by the trial authors. The
women in Soltan 2007 had given birth either at home or in hospital.
In two trials, women had PPH due to atony following caesarean
section (El-Sokkary 2016; Khalil 2011). The women in Kavak 2013
had PPH due to complete placenta praevia and intractable bleeding
following a caesarean section (Kavak 2013).
How was PPH defined in the trials?
We recorded the trial authors' definitions of PPH - these are
provided below.
Ashraf 2018 defined PPH as "excessive blood loss from genital tract
occurring during third stage of labour and within first 24 hours aFer
parturition" p 890.
Chantrapitak 2009 defined PPH as "blood loss > 500ml aFer
delivery" p 601.
Darwish 2018 provided no definition of PPH, nor was there a
systematic method of diagnosis.
Dumont 2017 defined PPH as, "visual estimation of excessive blood
loss and patient status (blood pressure and cardiac frequency)" p 2.
El-Sokkary 2016 did not define PPH.
Farouk 2016 defined PPH as blood loss more than 1000 mL within
two hours of birth.
Kavak 2013 did not define PPH.
Khalil 2011 did not define PPH.
Soltan 2007 did not define PPH in the trial report, and there is no
information on how blood loss was assessed.
Interventions and comparisons
External uterine compression versus usual care (comparison 1)
One trial (Chantrapitak 2009) compared external uterine
compression versus usual care. The study compared external
lower uterine compression with 'usual care'. External lower
uterine compression (either by grasping the uterus through a lax
abdominal wall or compressing the uterus against the sacrum and
lower vertebrae) was applied for a duration of 10 minutes. The
usual care group involved "massage, oxytocin (10-20 units in 1000
mL of intravenous solution, 200 mL/min), intravenous ergometrine
(Methergin®, 0.2 mg), placed cold pack on uterus, and urinary
catheterisation" p 601.
One uterine devascularisation technique versus another uterine
devascularisation technique
One trial compared one uterine devascularisation technique with
another technique of uterine devascularisation (Farouk 2016).
Uterine arterial embolisation versus surgical devascularisation plus B-
Lynch (comparison 2)
Farouk 2016 compared uterine arterial embolisation with surgical
devascularisation plus B-Lynch compression sutures.
Intrauterine balloon tamponade versus normal care
Condom-loaded Foley catheter plus normal care (misoprostol) versus
normal care (misoprostol) (comparison 3)
Dumont 2017 compared uterine balloon tamponade (condom-
loaded Foley catheter) and usual care (misoprostol) with usual care
(misoprostol) alone. All women received rectal misoprostol (1000
ug) or sublingually (600 ug) following randomisation. In the balloon
tamponade group, the condom was inflated "by increments of 250
mL of solute" p2. Further increments were added (up to a maximum
of 1000 mL) if bleeding was still evident five minutes aFer adding
the solution.
Latex balloon (air filled) tamponade + cervical stitch and normal care
(comparison 4)
Soltan 2007 compared uterine balloon tamponade the El-Menia
balloon tamponade versus normal care alone. The El-Menia balloon
tamponade is a standard latex party balloon (19 mm thick) inflated
to 140 mmHg and attached to a Nelton catheter with suture silk.
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To keep the balloon in place, cervical cerclage was applied ("at 3
and 9 o'clock" p54). Women in the balloon tamponade group also
received antibiotic prophylaxis immediately aFer balloon insertion
and every eight hours thereaFer for the subsequent three days.
Both groups received normal care, which consisted of uterine
massage and ecbolics as per the World Health Organization (WHO)
protocol.
Intrauterine tamponade versus another mechanical/surgical method
Bakri balloon tamponade versus haemostatic square suturing to the
lower segment of the uterus (comparison 5)
The Kavak 2013 trial compared Bakri balloon tamponade with
haemostatic square suturing to the lower segment of the uterus.
The Bakri balloon tamponade was inflated with saline (100 mL
to 200 mL) "according to the uterine size" p 706. Endouterine
haemostatic square suturing (four to five sutures) was applied to
the lower segment of the uterus.
All women were given prophylactic antibiotics.
One intrauterine tamponade technique versus another intrauterine
tamponade technique
Two trials compared one intrauterine tamponade technique versus
another intrauterine tamponade technique (Darwish 2018; Khalil
2011) - it was not possible to combine these data due to the nature
of the interventions under investigation.
Bakri balloon tamponade versus condom-loaded Foley catheter
(comparison 6)
Darwish 2018 compared Bakri balloon with a condom-loaded Foley
catheter. The Bakri balloon or condom-loaded Foley catheter was
positioned correctly and then inflated with saline (150 mL initially,
and subsequently inflated to 400 mL to 500 mL) until there was a
decrease in blood draining through the catheter.
Bakri balloon + traction stitch versus Bakri balloon without traction
stitch (comparison 7)
Khalil 2011 compared the use of Bakri balloon with a traction stitch
(to help hold it in place) with Bakri balloon without a traction
stitch. The trial report did not provide information about how much
saline was used to inflate the Bakri balloons. All women were given
intravenous antibiotics for the first 48 hours and oxytocin for the
first eight hours.
Condom-loaded catheter versus uterovaginal packing (comparison 8)
Ashraf 2018 compared the use of a condom-loaded catheter
intrauterine balloon tamponade with the use of uterovaginal
packing. Each intervention was leF in place for 24 hours and all
women were given prophylactic antibiotics (no further information
provided in the trial report).
One uterine compression suture technique versus another uterine
compression suture technique
Modified B-Lynch compression suture versus standard B-Lynch
compression suture (comparison 9)
El-Sokkary 2016 compared the standard B-Lynch compression
suture technique with a modified version of the technique in
which the sutures are applied in a figure of eight in order to
exert greater uterine compression than the standard B-Lynch
compression sutures.
Outcomes
Chantrapitak 2009 reported blood loss (mL) before treatment,
mean blood loss and standard deviations, and median blood
loss aFer treatment. Incidence of blood transfusion, and need for
additional uterotonic agent to control bleeding (prostaglandin)
were also reported.
Darwish 2018 reported the number of women who needed
some sort of further surgical intervention (i.e. hysterectomy, B-
Lynch compression suture) to stop bleeding. Secondary outcomes
included time (minutes) between intervention and cessation
of bleeding, blood transfusion, referral to intensive care unit,
development of disseminated intravascular coagulation (DIC), and
post-insertion fever.
Dumont 2017 employed a composite outcome as their primary
outcome - "the proportion of women with recourse to an
invasive surgery (arterial ligatures, uterine compression sutures,
hysterectomy) or who died before hospital discharge" (p3).
Secondary outcomes included, arterial ligations, uterine
compression sutures, hysterectomy to control bleeding, transfer to
intensive care, total blood loss greater than 1000 mL, and maternal
death.
The main outcome in El-Sokkary 2016 was whether the intervention
was successful: successful (cessation of bleeding and hysterectomy
not needed), unsuccessful (bleeding continued and hysterectomy
needed). Other outcomes reported include postoperative blood
loss; hysterectomy; blood transfusion; hospital stay; duration of
the procedure; pre- and postoperative haemoglobin (Hb); bleeding
from multiple bites; haematoma; wound haematoma; wound
infection; fever.
Farouk 2016 reported cessation of bleeding, hysterectomy to
control bleeding, postpartum fever (temperature > 38.5 deg C), and
complications.
Kavak 2013 reported mortality, hysterectomy, intraoperative blood
loss and blood transfusion as well as postoperative blood loss.
Postoperative Hb and haematocrit are also reported along with
'time of operation' (assumed to be duration). Adverse eEects were
also recorded along with postoperative fever. We tried to contact
the authors to provide data on post-randomisation blood loss only
(rather than the quoted 'intrapartum blood loss') but we did not
receive a response. We therefore used the data provided on 'total
intrapartum blood loss' assuming that the randomisation process
would equalise the pre-randomisation blood loss between the two
arms of the study.
Khalil 2011 reports the 'estimated blood loss', 'hysterectomy
required', 'other surgeries required', along with three outcomes
not in this review: 'displacement of the balloon', 'bleeding aFer
displacement of the balloon', and 'bleeding aFer deflation of
balloon'. The author provided data on the number of women with
blood loss of 1000 mL and with blood loss over 1000 mL. The
continuous variable for blood loss was provided as mean and range
only (not mean and standard deviation), so it was not possible to
use this outcome.
The primary outcome in the Soltan 2007 trial was maternal
mortality. Secondary outcomes were treatment failure, abdominal
hysterectomy, surgical operations, reinsertion of the balloon,
balloon rupture, pyrexia, allergic reactions, The author provided
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data on units of syntocinon and ampoules of ergometrine, but
these were provided as means and standard deviations and it is
unclear whether these were 'additional' uterotonics or part of the
normal care (WHO ecobolic protocol) that both groups received.
Similarly, the author provided continuous data for number of units
of blood transfused, and days stay in intensive care unit, but since
these are in mean and standard deviation format it is not possible to
identify the number of women in each group with these outcomes.
Soltan 2007 also reported Hb and haematocrit on discharge, time
to resuscitate, and time to regain normal uterine tone. Soltan 2007
reports that 19 women in the normal care group were given the
intervention (El-Menia balloon) because bleeding did not stop. The
women remain in the 'control' group despite having received the
intervention thus preserving intention-to-treat but since these data
were not reported separately we are unaware of the impact that this
may have on the outcome data for the control group.
The Ashraf 2018 reports fever (side eEect of the intervention)
relevant to the outcomes in this review. The study also reported
on the following outcomes not featured in this review: Mean
blood loss; eEicacy (defined as blood loss stopped within 15
minutes of insertion and no recurrence of bleeding aFer removal of
tamponade/packing); safety (no infection or fever; perforation (no
further information given).
Sources of trial funding
Sources of trial funding were not mentioned in seven studies
(Chantrapitak 2009; Darwish 2018; El-Sokkary 2016; Farouk 2016;
Kavak 2013, Khalil 2011; Soltan 2007). Dumont 2017, was funded by
the Research Institute for Development (IRD) and United Nations
Children's Fund (UNICEF). Ashraf 2018 reported that there were no
sources of trial funding.
Trial authors' declarations of interest
Six trial authors reported that they had no conflicts of interest
(Darwish 2018; Dumont 2017; El-Sokkary 2016; Kavak 2013; Khalil
2011; Ashraf 2018). Trial authors' declarations were not mentioned
in Chantrapitak 2009, Farouk 2016 or Soltan 2007.
Was informed consent obtained from the trial participants?
Five trials reported that consent was sought from the trial
participants (Darwish 2018; Dumont 2017; Farouk 2016; Kavak
2013; Khalil 2011), and in one trial (Soltan 2007), informed consent
was sought from the women's husbands. Informed consent was
not mentioned in two trials (Chantrapitak 2009; El-Sokkary 2016).
Ashraf 2018 reports that informed consent was obtained from the
women regarding "using their data for study purpose" p891, but it
is not clear whether the women gave informed consent to receive
the intervention.
Was ethical approval sought?
Seven trials reported having obtained ethical approval for the
trial (Darwish 2018; Dumont 2017; El-Sokkary 2016; Farouk 2016;
Kavak 2013; Khalil 2011; Soltan 2007), but ethical approval was not
mentioned in Chantrapitak 2009. In the Ashraf 2018 trial report,
it states, "ethical approval: Given" p902 but not further detail is
provided.
Excluded studies
We excluded 17 trials.
Two trials were quasi-RCTs (Soltan 2009; Soltan 2010), and four
were only available in abstract and had insuEicient information
to assess risk of bias (Gelany 2012; Khalil 2014; Mohamed 2014;
von Beckerath 2016). One trial (Anger 2016) was a stepped-
wedge cluster-RCT which randomised 18 hospitals to a policy of
introducing uterine balloon tamponade (UBT) into standard care.
The participants included all women (not just women with PPH)
and sensitivity analysis for women with PPH was not provided. One
trial (Letouzey 2013), comparing Bakri balloon versus routine care
was terminated due to recruitment diEiculties. One trial (Rahman
2015), comparing Tampostat (TM) balloon tamponade device versus
a condom catheter tamponade was also terminated.
Six trials were prevention of PPH studies (Azmy 2016; Chen 2017;
Farouk 2018; Nermeen 2015; Rezk 2016; Sallam 2019). One trial
was not an RCT (Purwosonu 2015), and one other (Liu 2016), was a
comparison of two diEerent nursing methods for women who had
all had uterine embolisation for PPH.
See Characteristics of excluded studies for further information.
Risk of bias in included studies
Overall, the included trials were at an unclear risk of bias. See Figure
2 and Figure 3.
 
Mechanical and surgical interventions for treating primary postpartum haemorrhage (Review)









Cochrane Database of Systematic Reviews





























































































































































Ashraf 2018 + ? - ? + - ?
Chantrapitak 2009 ? ? - ? - ? +
Darwish 2018 + + - - - ? +
Dumont 2017 + - - - + + -
El-Sokkary 2016 + ? - ? ? ? +
Farouk 2016 + ? - ? + ? +
Kavak 2013 ? ? - ? + ? +
Khalil 2011 + ? - ? + ? +
Soltan 2007 + + - ? + ? -
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Figure 3.   'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
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We assessed seven studies as low risk of bias for sequence
generation (Ashraf 2018; Darwish 2018; Dumont 2017; El-Sokkary
2016; Farouk 2016; Khalil 2011; Soltan 2007). Methods included
computer-generated random tables (Darwish 2018; Dumont 2017;
El-Sokkary 2016), a computer-generated list (Farouk 2016),
computer-based randomisation (Khalil 2011;Soltan 2007,) or using
the lottery method (Ashraf 2018).
In Chantrapitak 2009 and Kavak 2013, the methods of sequence
generation were unclear. Chantrapitak 2009 reported that the two
groups were 'equally divided' and were 'randomly assigned' to the
treatment groups, and Kavak 2013 reported that the participants
were 'randomly divided' - but in both cases, no further information
was provided.
Allocation concealment
We assessed two trials as being low risk of bias for allocation
concealment. Darwish 2018 used serially numbered opaque sealed
envelopes. Soltan 2007 used closed opaque envelopes.
We assessed the remaining seven studies as being at unclear risk
of bias. No information pertaining to allocation concealment was
mentioned in Ashraf 2018; Chantrapitak 2009; Kavak 2013; and
Khalil 2011. Two trials (El-Sokkary 2016; Farouk 2016) mentioned
'closed' or 'sealed' envelopes, but it was not clear whether
these were sequentially numbered opaque sealed envelopes. In
Dumont 2017 - the randomisation code was known to four people
(suggesting this was a revealed list) and the trial supervisor decided
over the telephone whether to randomise or not.
Blinding
Blinding of participants and personnel (performance bias)
The studies of Darwish 2018 and Kavak 2013 were described as
single-blinded. In both Darwish 2018 and Kavak 2013, it is not
specified who was blinded, but presumably it was the patients who
were all under general anaesthetic. The surgeons could not have
been blinded due to the nature of the intervention, and so the
risk of bias is still judged to be 'high risk' (please refer to Figure
2. Chantrapitak 2009, Dumont 2017, El-Sokkary 2016, Khalil 2011,
Farouk 2016 and Soltan 2007 used closed opaque envelopes to
conceal allocation, but there was no blinding reported. Blinding
was not mentioned in Ashraf 2018. Blinding was diEicult in all of
these studies because the investigators were also the surgeons
who were the involved in applying the surgical techniques - it is
therefore very diEicult to blind them.
Blinding of outcome assessors (detection bias)
The outcome data were not reported to be blinded in any of the
studies and we assessed seven of trials as 'unclear' risk of detection
bias. We assessed two trials as being at a high risk of detection
bias. In the Darwish 2018 trial, it is possible that non-independent
blinded providers have biased the outcomes assessments. In the
Dumont 2017 it is possible that non-independent blinded providers
have biased the outcomes assessments (please refer to Figure 2).
Incomplete outcome data
We assessed one trial Chantrapitak 2009) to be at a high risk of
attrition bias. In the trial report, there are two women with cervical
and vaginal tears whose outcomes are not reported. It is unclear
whether these were excluded before or aFer randomisation.
However, cervical and vaginal tears are only usually found upon
detailed examination aFer failure of primary treatment (in this case
oxytocics plus uterine compression). It therefore seems likely that
they were excluded aFer randomisation.
In the Darwish 2018 study, the study's main outcomes were
reported for all 66 women recruited. However, treatment failed
in eight women across the study and they went on to have
either the insertion of a B-Lynch compression suture (n = 5) or
a hysterectomy (n = 3). The study's secondary outcome data on
blood transfusion, intensive care unit referral, DIC and fever were
not reported for these eight women and the data in the trial report
relate to the remaining 58 (analysed 'per protocol'). The incomplete
data (especially given that they were the ones who had the worst
outcomes) led to a score of 'high risk' for attrition bias.
We assessed six trials as being at low risk of attrition bias (Ashraf
2018; Dumont 2017; Farouk 2016; Kavak 2013; Khalil 2011; Soltan
2007).
We assessed one trial El-Sokkary 2016 as 'unclear' for this domain
because, in table 1 of the trial report, the authors did not state the
number of women. In the text, there was no mention of incomplete
data but we cannot assume that data were complete.
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Selective reporting
In six trials there was no mention of a protocol and we assessed
these trials as having an unclear risk of reporting bias (Chantrapitak
2009; El-Sokkary 2016; Farouk 2016; Kavak 2013; Khalil 2011; Soltan
2007). We assessed Darwish 2018 as unclear risk of bias - whilst
the trial was prospectively registered, there are outcomes in the
trial report that were not mentioned in the protocol. Similarly,
Dumont 2017 was prospectively registered but there were some
minor diEerences between the outcomes in the protocol and the
published trial report, but we assessed the trial as low risk of
reporting bias. We assessed Ashraf 2018 as having a high risk of
bias for selective reporting - a protocol was not available for this
study. We note that one outcome (perforation) not detailed in the
methods, is reported in the results. Generally, there are very few
outcomes reported, including none of the outcomes listed in the
article background, and there are no escalation outcomes reported
(e.g. hysterectomy due to bleeding). It is also unclear from the
report whether the mean blood loss outcome is pre-randomisation
(i.e. a participant characteristic) or post-randomisation.
Other potential sources of bias
We assessed six studies as low risk of other bias as no other
potential sources of bias were identified. The remaining three trials
were at unclear (Ashraf 2018) and high (Dumont 2017; Soltan 2007)
risk of other bias.
Ashraf 2018 was assessed as having an unclear risk of other
bias - the trial methods contain discrepancies with the reported
participant characteristics and there is no mention of whether the
women also received usual care in addition to the interventions of
interest and, if so, what that was comprised of. Soltan 2007 was
assessed as having a high risk of other bias because 19 women in
the control group also received the intervention as a second-line
treatment. This secondary use of UBT was not prespecified in the
methods
EBects of interventions
See: Summary of findings 1 External uterine compression
(all methods) plus normal care compared to normal care
for treating primary postpartum haemorrhage; Summary of
findings 2 One uterine devascularisation technique (uterine
arterial embolisation) versus another uterine devascularisation
technique (surgical devascularisation plus B-Lynch); Summary
of findings 3 Intrauterine balloon tamponade plus normal
care (misoprostol) compared to normal care (misoprostol)
for treating primary postpartum haemorrhage; Summary of
findings 4 Intrauterine balloon tamponade (latex balloon
inflated with air) plus cerclage and normal care compared
to normal care for treating primary postpartum haemorrhage;
Summary of findings 5 Bakri balloon tamponade versus
haemostatic square suturing to the lower segment of the
uterus (intrauterine tamponade versus another mechanical/
surgical method) for treating primary postpartum haemorrhage;
Summary of findings 6 Bakri balloon tamponade versus condom-
loaded Foley Catheter (one intrauterine tamponade compared to
another intrauterine tamponade technique) for treating primary
postpartum haemorrhage; Summary of findings 7 Bakri balloon
tamponade+traction stitch versus Bakri balloon (one intrauterine
tamponade compared to another intrauterine tamponade
technique) for treating primary postpartum haemorrhage);
Summary of findings 8 Intrauterine balloon tamponade (condom-
loaded catheter) versus uterovaginal packing (intrauterine
tamponade versus another intrauterine tamponade method) for
treating primary postpartum haemorrhage; Summary of findings
9 Modified B-Lynch compression suture technique versus standard
B-Lynch compression suture (one uterine compression suture
technique versus another uterine compression suture technique)
for treating primary postpartum haemorrhage
We included nine small studies, involving a total of 944 women with
primary PPH following either caesarean section or vaginal birth. It
was not possible to combine any of the studies in meta-analysis
due to diEerences in the interventions and comparisons under
investigation. We therefore present outcome data for individual
studies below. Outcomes that form part of a core outcome set
that will be used in all PPH reviews are highlighted below with an
asterisk.
External uterine compression versus normal care (external
uterine compression versus normal care) (comparison 1)
One small study (Chantrapitak 2009) contributed data to this
comparison. The study, which involved 64 women diagnosed with
uncontrolled primary PPH following vaginal birth. The study was
conducted in Thailand and examined the use of external lower
uterine compression versus usual care for treating primary PPH.
Primary outcomes
Mortality due to bleeding
This outcome was not reported in the included study under this
comparison.
Hysterectomy to control bleeding
This outcome was not reported in the included study under this
comparison.
Serious maternal morbidity (renal or respiratory failure, cardiac arrest
or multiple organ failure)
This outcome was not reported in the included study under this
comparison.
Secondary outcomes
Mean blood loss (mL) (trialist defined)*
Chantrapitak 2009 reported amount of blood loss (mL) aFer
treatment (data were reported as medians with interquartile range
- external uterine compression:120 mL (∓ 211.0 mL); normal care:
225.0 mL (∓ 401.0 mL).
Blood transfusion (red cell or whole blood)*
Very low-certainty evidence means that we are unclear about
the evidence relating to the incidence of red cell or whole blood
transfusion (risk ratio (RR) 2.33, 95% confidence interval (CI) 0.66
to 8.23; 64 women; 1 study; Analysis 1.1). There were 7/32 women
with red cell or whole blood transfusion in the external uterine
compression group and 3/32 women in the normal care control.
Post-randomisation additional uterotonic agent used to control
bleeding*
Two of the 32 women in the external uterine compression
group and 3/32 women in the normal care group required post-
randomisation additional uterotonic agent to control bleeding (RR
0.67, 95% CI 0.12 to 3.73; 64 women, 1 study).
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Secondary outcomes not reported by the study under this comparison
The following secondary outcomes of interest in this review were
not reported in the one included study under this comparison.
• All-cause mortality*
• Mortality from causes other than bleeding
• Shock as defined by trialist*
• Coagulopathy as defined by trialist*
• Number of women with total blood loss 500 mL or more aFer
randomisation*
• Number of women with total blood loss 1000 mL or more aFer
randomisation*
• Blood product transfusion*
• Post-randomisation additional surgical interventions used to
control bleeding (arterial ligation, compressive, uterine sutures,
arterial embolisation, laparotomy)*
• Post-randomisation additional non-surgical intervention to
control bleeding (uterine packing, bimanual uterine massage,
tamponade, external aortic compression and compression
garments)
• Admission to higher level of care*
• Side eEects of the intervention (e.g. trauma, necrosis)
• Days in hospital
• Breastfeeding (defined as any breastfeeding at hospital
discharge)*
• Maternal satisfaction with therapy (trialist defined)*
• Quality of life, including physiological activity and social and
emotional changes (sense of well-being) (trialist defined)*
Uterine arterial embolisation versus surgical
devascularisation plus B-Lynch (One uterine devascularisation
technique versus another uterine devascularisation technique)
(comparison 2)
One small study (Farouk 2016) contributed data to this comparison.
The study was conducted in Egypt and examined the use of uterine
arterial embolisation (UAE) versus surgical devascularisation
for treating primary PPH. The study involved 23 women with
uncontrolled primary atonic PPH following vaginal delivery (9/11 in
the UAE group and 8/12 in the surgical devascularisation+B-Lynch
group) or caesarean section (2/11 in the UAE group and 4/12 in the
surgical devascularisation+B-Lynch group).
Primary outcomes
Mortality due to bleeding
This outcome was not reported by Farouk 2016.
Hysterectomy to control bleeding
Very low-certainty evidence means that we are unclear about the
results for hysterectomy to control bleeding, with 2/11 women
having hysterectomy to control bleeding in the uterine arterial
embolisation group compared with 3/12 women in the surgical
devascularisation+ B-Lynch group (RR 0.73, 95% CI 0.15 to 3.57; 23
women, 1 study; Analysis 2.1).
Serious maternal morbidity (renal or respiratory failure, cardiac arrest
or multiple organ failure)
This outcome was not reported by Farouk 2016.
Secondary outcomes
Side eBects of the intervention (e.g. trauma, necrosis)
Very low-certainty evidence means we are unclear about the results
for this outcome, with just one woman in each group reporting side
eEects (RR 1.09, 95% CI 0.08 to 15.41; 23 women, 1 study). One
woman in the embolisation group reported gluteal pain and one
women in the surgical group had bladder injury. There were other
'complications' in each group (sepsis, fever, renal failure) but we
do not consider these to be side eEects of the intervention. See
Analysis 2.2.
Secondary outcomes not reported by the study under this comparison
• All-cause mortality*
• Mortality from causes other than bleeding
• Shock as defined by trialist*
• Number of women with total blood loss 500 mL or more aFer
randomisation*
• Number of women with total blood loss 1000 mL or more aFer
randomisation*
• Mean blood loss (mL) (trialist defined)*
• Coagulopathy as defined by trialist*
• Blood transfusion (red cell or whole blood)*
• Blood product transfusion*
• Post-randomisation additional uterotonic agent used to control
bleeding*
• Post-randomisation additional surgical interventions used to
control bleeding (arterial ligation, compressive, uterine sutures,
arterial embolisation, laparotomy)*
• Post-randomisation additional non-surgical intervention to
control bleeding (uterine packing, bimanual uterine massage,
tamponade, external aortic compression and compression
garments)
• Admission to higher level of care*
• Days in hospital
• Breastfeeding (defined as any breastfeeding at hospital
discharge)*
• Maternal satisfaction with therapy (trialist defined)*
• Quality of life, including physiological activity and social and
emotional changes (sense of well-being) (trialist defined)*
Intrauterine balloon tamponade plus normal care
(misoprostol) versus normal care (misoprostol) (intrauterine
tamponade versus normal care) (comparison 3)
One small study (Dumont 2017) contributed data to this
comparison. In this multi-centre study, which involved 116
women with primary PPH (thought to be due to clinical atony)
following vaginal birth. The study was conducted in seven diEerent
healthcare facilities in Benin and Mali and examined the use of
an intrauterine balloon tamponade plus normal are (misoprostol)
versus usual care (misoprostol) alone for treating primary PPH.
Primary outcomes
Mortality due to bleeding
Due to very low-certainty evidence, we are unclear about the results
for maternal mortality due to bleeding (RR 6.21, 95% CI 0.77 to
49.98; 116 women, 1 study; very low-certainty evidence; Analysis
3.1). There were 6/57 maternal deaths due to bleeding in the
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intrauterine tamponade group compared to 1/59 in the normal care
control.
Hysterectomy to control bleeding
Similarly, very low-certainty evidence for the outcome
'hysterectomy to control bleeding' means that we are unclear about
the results for this outcome (RR 4.14, 95% CI 0.48 to 35.93; 116
women, 1 study; very low-certainty evidence; Analysis 3.2).
Serious maternal morbidity (renal or respiratory failure, cardiac arrest
or multiple organ failure)
This outcome was not reported by Dumont 2017.
Secondary outcomes
All-cause mortality*
There were 6/57 all cause maternal deaths in the intrauterine
tamponade group compared to 1/59 in the normal care control (RR
6.21, 95% CI 0.77 to 49.98; 116 women, 1 study; Analysis 3.3).
Mortality from causes other than bleeding
There were no maternal deaths in either group resulting from
causes other than bleeding. Analysis 3.4.
Number of women with total blood loss 1000 mL or more a?er
randomisation*
Balloon tamponade may increase the incidence of total blood
loss 1000 mL or more aFer randomisation, but the evidence
is of very low certainty (RR 1.52, 95% CI 1.15 to 2.00, 113
women, 1 study; low-certainty evidence; Analysis 3.5). There were
43/54 women with this outcome in the intrauterine tamponade
group compared to 31/59 women receiving standard care. The
reported blood loss includes all blood lost postnatally, rather than
that just following randomisation. However, we have assumed
that the correct randomisation has equally distributed the pre-
randomisation blood loss between the two study arms.
Blood transfusion (red cell or whole blood)*
We found very low-certainty evidence relating to blood transfusion
which means we are unclear about the results for this outcome (RR
1.49, 95% CI 0.88 to 2.51; 116 women, 1 study).
Post-randomisation additional surgical interventions used to control
bleeding (arterial ligation, compressive, uterine sutures, arterial
embolisation, laparotomy)*
Additional surgical interventions to control bleeding included
uterine compression sutures (2/57 in the intrauterine tamponade
group and 0/59 in normal care group) and artery ligation (4/57
in the intrauterine tamponade group and 3/59 in the normal care
group). See Analysis 3.7. Very low-certainty evidence means we are
uncertain about the results for this outcome.
Admission to higher level of care*
The number of women admitted to a higher level of care was
(10/57) in the intrauterine tamponade group (10/57) and 8/59 in
the standard care group (8/59) (RR 1.29, 95% CI 0.55 to 3.04; 116
women, 1 study; Analysis 3.8).Very low-certainty evidence means
the results are unclear for this outcome.
Side eBects of the intervention (e.g. trauma, necrosis)
We are uncertain about the results for this outcome due to
very low-certainty evidence. Dumont 2017 reported that none
of the women in either group experienced side eEects of the
intervention (reported as severe shivering, diarrhoea, vomiting or
high temperature). See Analysis 3.9.
Secondary outcomes not reported by the study under this comparison
• Shock as defined by trialist*
• Coagulopathy as defined by trialist*
• Number of women with total blood loss 500 mL or more aFer
randomisation*
• Mean blood loss (mL) (trialist defined)*
• Blood product transfusion*
• Post-randomisation additional uterotonic agent used to control
bleeding*
• Post-randomisation additional non-surgical intervention to
control bleeding (uterine packing, bimanual uterine massage,
tamponade, external aortic compression and compression
garments)
• Days in hospital
• Breastfeeding (defined as any breastfeeding at hospital
discharge)*
• Maternal satisfaction with therapy (trialist defined)*
• Quality of life, including physiological activity and social and
emotional changes (sense of well-being) (trialist defined)*
Latex balloon (inflated with air) tamponade plus cerclage
and normal care versus normal care (intrauterine tamponade
versus normal care) (comparison 4)
One small study (Soltan 2007) contributed data to this comparison.
The study, which involved 240 women with PPH due to uterine
atony following vaginal birth. Women had given birth in either
at home or in hospital. The study was conducted in Egypt and
examined the use of a latex  party balloon inflated with air and
attached to a catheter with suture silk, the balloon was held
in place with a cervical stitch. Women in the comparison group
received standard care which comprised of uterine massage and
ecbolics as per WHO protocol. Women in the intervention group
also received antibiotics (metronidazole 500 mg, gentamycin 80 mg
and ampicillin 500 mg aFer the balloon was inserted, and every
eight hours for three days.
The trial protocol for Soltan 2007 stated that all of the women
in the control group would receive standard care as the first-
line treatment. However, 19/120 women in the control group
subsequently received the intervention as a second-line treatment.
The authors preserved intention-to-treat (the 19 women remained
in the control group).
Primary outcomes
Mortality due to bleeding
There were no maternal deaths due to bleeding.
Hysterectomy to control bleeding
Very low-certainty evidence for the outcome 'hysterectomy to
control bleeding' means that we are unclear about the results for
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this outcome (RR 0.14, 95% CI 0.01 to 2.74; 240 women, one study;
Analysis 4.2).
Serious maternal morbidity (renal or respiratory failure, cardiac arrest
or multiple organ failure)




There were no mortalities reported in Soltan 2007.
Mortality from causes other than bleeding
There were no mortalities from causes other than bleeding
reported in Soltan 2007.
Days in hospital
The length of time (days) that women spent in hospital appeared to
be shorter in the intervention group compared to the normal care
group but we are uncertain about this result because the evidence
was very low certainty (MD -1.20 days, 95% CI -1.33 to -1.07; 240
women; one study; Analysis 4.5).
Post-randomisation additional surgical interventions used to control
bleeding (arterial ligation, compressive, uterine sutures, arterial
embolisation, laparotomy)
Two women in the control group required additional post-
randomisation surgical interventions (B-lynch suture and artery
ligation) in order to control bleeding compared to the intervention
group where no women required additional surgical interventions
to control bleeding (RR 0.20, 95% CI 0.01 to 4.12; 240 women, one
study; Analysis 4.6)
*Post-randomisation additional non-surgical intervention to control
bleeding (uterine packing, bimanual uterine massage, tamponade,
external aortic compression and compression garments)
The Soltan 2007 trial methods specified that all women in
the control group would receive standard care as the first-
line treatment. However, 19/120 women in the control group
subsequently received the intervention as a second-line treatment
(RR 0.03, 95% CI 0.00 to 0.42; 240 women, one study; Analysis 4.7).
Side eBects of the intervention (e.g. trauma, necrosis)
Soltan 2007 reported that there were no cases of pyrexia, or allergic
reaction - Analysis 4.8.
The trial report also mentioned that quote: "undesired over inflation
of the balloon, has results in three complications; two cases of
cervical tear treated with surgical repair under general anaesthesia.
The third one was a raise of uterine size above umbilicus; associated
with tachycardia and hypotension, which had returned back to
normal a$er deflation of the balloon bringing the uterine level just
below the umbilicus" (Soltan 2007 page 59). However, it is unclear
which group the three women were from (given that 19/120 women
in the control group subsequently received the intervention as a
second-line treatment). We attempted to contact the author for
clarification (20 January 2020) but received no response.
Secondary outcomes not reported by the study under this comparison
The following prespecified secondary outcomes in this review were
not reported by the included study/studies under this comparison.
• Shock as defined by trialist*
• Coagulopathy as defined by trialist*
• Number of women with total blood loss 500 mL or more aFer
randomisation*
• Number of women with total blood loss 1000 mL or more aFer
randomisation*
• Mean blood loss (mL) (trialist defined)*
• Blood transfusion (red cell or whole blood)*
• Blood product transfusion*
• Post-randomisation additional uterotonic agent used to control
bleeding*
• Admission to higher level of care*
• Breastfeeding (defined as any breastfeeding at hospital
discharge)*
• Maternal satisfaction with therapy (trialist defined)*
• Quality of life, including physiological activity and social and
emotional changes (sense of well-being) (trialist defined)*
Bakri balloon tamponade versus haemostatic square suturing
to the lower segment of the uterus (intrauterine tamponade
versus another mechanical/surgical method) (comparison 5)
One very small study (Kavak 2013) contributed data to this
comparison. The study, which involved 13 women with placenta
praevia and primary PPH following caesarean section. The study
was conducted in Turkey and examined the use of a Bakri balloon
versus endouterine haemostatic square suturing to the lower
segment of the uterus for treating primary PPH.
Primary outcomes
Mortality due to bleeding
The eEects of intervention on maternal mortality due to bleeding
are unclear due to very low-certainty evidence. There were no
maternal deaths in either group. See Analysis 5.1.
Hysterectomy to control bleeding
The eEects of intervention on hysterectomy to control bleeding
are also unclear due to very low-certainty evidence. There were no
hysterectomies to control bleeding in either group. See Analysis 5.2.
Serious maternal morbidity (renal or respiratory failure, cardiac arrest
or multiple organ failure)
The eEects of intervention on serious maternal morbidity are also
unclear, again due to very low-certainty evidence. There were no
serious maternal morbidities in either group. See Analysis 5.3.
Secondary outcomes
Mean blood loss (mL) (trialist defined)*
Bakri balloon tamponade may reduce mean 'intraoperative'
blood loss (mL) compared to haemostatic square suturing (mean
diEerence (MD) -426 mL, 95% CI -631.28 to -220.72; very low-
certainty evidence; Analysis 5.6)), but we are uncertain about this
result because the evidence was very low certainty .
Mechanical and surgical interventions for treating primary postpartum haemorrhage (Review)









Cochrane Database of Systematic Reviews
Blood transfusion (red cell or whole blood)*
We found very low-certainty evidence relating to blood transfusion
(red cell or whole blood) which means we are uncertain about the
results for this outcome. There were 2/7 events in the intrauterine
tamponade group and 3/6 in the uterine compression (control)
group (RR 0.57, 95% CI 0.14 to 2.36, 13 women, 1 study; very low-
certainty evidence; Analysis 5.7).
Post-randomisation additional surgical interventions used to control
bleeding (arterial ligation, compressive, uterine sutures, arterial
embolisation, laparotomy)*
No women in either group required additional surgical
interventions to control bleeding (13 women, one study). See
Analysis 5.8.
Side eBects of the intervention (e.g. trauma, necrosis)
Kavak 2013 reported that there were no adverse eEects requiring
surgical intervention in either group, however there were two cases
of fever in the control group. See Analysis 5.9. We identified very
low-certainty evidence for both of these outcomes which means we
are uncertain about the results.
Postnatal blood loss (outcome not prespecified in our review protocol)
Kavak 2013 reported on postnatal blood loss associated with
the use of intrauterine tamponade compared with another
mechanical/surgical method (haemostatic sutures) (MD -231.00
mL, 95% CI -300.70 to -161.30; 13 women, 1 study; Analysis 5.10) but
this is very low-certainty evidence which means we are uncertain
about the results for this outcome.
Secondary outcomes not reported by the study under this comparison
• All-cause mortality*
• Mortality from causes other than bleeding
• Shock as defined by trialist*.
• Coagulopathy as defined by trialist*
• Number of women with total blood loss 500 mL or more aFer
randomisation*
• Number of women with total blood loss 1000 mL or more aFer
randomisation*
• Blood product transfusion*
• Post-randomisation additional uterotonic agent used to control
bleeding*
• Post-randomisation additional non-surgical intervention to
control bleeding (uterine packing, bimanual uterine massage,
tamponade, external aortic compression and compression
garments)
• Admission to higher level of care*
• Days in hospital
• Breastfeeding (defined as any breastfeeding at hospital
discharge)*
• Maternal satisfaction with therapy (trialist defined)*
• Quality of life, including physiological activity and social and
emotional changes (sense of well-being) (trialist defined)*
Bakri balloon tamponade versus condom-loaded Foley
catheter (one intrauterine tamponade technique versus
another intrauterine tamponade technique) (comparison 6)
One small study (Darwish 2018) contributed data to this
comparison. The study, which involved 66 women with
uncontrolled primary atonic PPH following vaginal birth. The study
was conducted in Egypt and examined the use of a Bakri balloon
versus a condom-loaded Foley catheter for treating primary PPH.
It is important to note that women in whom the treatment failed
were excluded from the results for the trial's secondary outcomes,
making it diEicult to draw conclusions from the published results.
Primary outcomes
Mortality due to bleeding
This outcome was not reported in the included study under this
comparison.
Hysterectomy to control bleeding
The certainty of the evidence is very low, which means that it is
uncertain whether the Bakri balloon tamponade reduces the risk of
hysterectomy to control bleeding: Bakri balloon group (1/33) versus
condom-loaded Foley catheter group (2/33) (RR 0.50, 95% CI 0.05 to
5.25; 66 women, 1 study; Analysis 6.1).
Serious maternal morbidity (renal or respiratory failure, cardiac arrest
or multiple organ failure)
This outcome was not reported in the included study under this
comparison.
Secondary outcomes
Mean blood loss (mL) (trialist defined)*
Blood transfusion (red cell or whole blood)*
We are uncertain of the eEects of intervention on the risk of blood
transfusion (red cell or whole blood) between the Bakri balloon
and condom-loaded Foley catheter groups because the evidence
is very low certainty. There were 29/30 events in the Bakri balloon
group and 28/28 in the condom-loaded Foley catheter group (RR
0.97, 95% CI 0.88 to 1.06, 58 women - eight women with 'treatment
failure' excluded from these data, 1 study; Analysis 6.3).
Post-randomisation additional surgical interventions used to control
bleeding (arterial ligation, compressive, uterine sutures, arterial
embolisation, laparotomy)*
There were 2/33 women in the Bakri balloon group who needed
additional surgical interventions (B-Lynch compression sutures) to
control bleeding and (3/33) in the condom-loaded Foley catheter
group (RR 0.67, 95% CI 0.12 to 3.73; 66 women; Analysis 6.4). These
results are unclear due to very low-certainty evidence.
Admission to higher level of care*
The number of women who were admitted to a higher level of care
was 2/30 in the Bakri balloon group (2/30) and 4/28 in the condom-
loaded Foley catheter group (RR 0.47, 95% CI 0.09 to 2.35; 66 women
but with five women with 'treatment failure' excluded from this
data, 1 study; Analysis 6.5). Very low-certainty evidence means we
are unclear about the results for this outcome.
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Coagulopathy (as defined by trialist)
The number of women who developed coagulopathy (reported
as 'Disseminated Intravascular Coagulopathy' or 'DIC') was 1/30
in the Bakri balloon group and 2/28 in the condom-loaded Foley
catheter group (RR 0.47, 95% CI 0.04 to 4.87; 58 women but five with
'treatment failure' excluded from this data, 1 study; Analysis 6.2).
Very low-certainty evidence means we are unclear about the results
for this outcome.
Secondary outcomes not reported by the study under this comparison
• All-cause mortality*
• Mortality from causes other than bleeding
• Shock as defined by trialist*
• Number of women with total blood loss 500 mL or more aFer
randomisation*
• Number of women with total blood loss 1000 mL or more aFer
randomisation*
• Blood product transfusion*
• Post-randomisation additional uterotonic agent used to control
bleeding*
• Post-randomisation additional non-surgical intervention to
control bleeding (uterine packing, bimanual uterine massage,
tamponade, external aortic compression and compression
garments)
• Side eEects of the intervention (e.g. trauma, necrosis)
• Days in hospital
• Breastfeeding (defined as any breastfeeding at hospital
discharge)*
• Maternal satisfaction with therapy (trialist defined)*
• Quality of life, including physiological activity and social and
emotional changes (sense of well-being) (trialist defined)*
Bakri balloon + traction stitch versus Bakri balloon without
traction stitch (one intrauterine tamponade versus another
intrauterine tamponade technique (comparison 7)
One small study (Khalil 2011) contributed data to this comparison.
The study, which involved 50 women with uncontrolled primary
atonic PPH following caesarean section. The study was conducted
in Saudi Arabia and examined the use of a Bakri balloon held in
place with a traction stitch versus Bakri balloon without traction
stitch for treating primary PPH.
Primary outcomes
Mortality due to bleeding
This outcome was not reported by Khalil 2011.
Hysterectomy to control bleeding
We are uncertain about the results for hysterectomy to control
bleeding because the evidence was very low certainty. There were
0/25 women who had hysterectomy to control bleeding in the group
of women who received Bakri balloon+traction stitch and 2/25
women who had hysterectomy to control bleeding in the group who
received Bakri balloon without traction stitch (RR 0.20, 95% CI 0.01
to 3.97; 50 women, 1 study; Analysis 7.1).
Serious maternal morbidity (renal or respiratory failure, cardiac arrest
or multiple organ failure)
This outcome was not reported by Khalil 2011.
Secondary outcomes
Post-randomisation additional surgical interventions used to control
bleeding (arterial ligation, compressive, uterine sutures, arterial
embolisation, laparotomy)*
The incidence of post-randomisation additional non-surgical
interventions to control bleeding was 1/25 in the Bakri+traction
stitch group, where the woman in the intervention group received
uterine artery embolisation) and 3/25 in the Bakri balloon without
traction stitch group, where al three women received uterine artery
ligation and iliac artery ligation (RR 0.33, 95% CI 0.04 to 2.99, 50
women, 1 study; Analysis 7.2). Very low-certainty evidence means
we are unclear about the results for this outcome.
Total blood loss >/= 1000 mL before and a?er randomisation (outcome
not prespecified in our review protocol)
Khalil 2011 reported 100% of women in both groups had a total
blood loss of greater than or equal to 1000 mL (RR 1.00, 95% CI 0.93
to 1.08; 50 women, 1 study; low-certainty evidence; Analysis 7.3).
Secondary outcomes not reported by the study under this comparison
The following prespecified secondary outcomes in this review were
not reported by the included study/studies under this comparison.
• All-cause mortality*
• Mortality from causes other than bleeding
• Shock as defined by trialist*
• Coagulopathy as defined by trialist*
• Number of women with total blood loss 500 mL or more aFer
randomisation*
• Number of women with total blood loss 1000 mL or more aFer
randomisation*
• Mean blood loss (mL) (trialist defined)*
• Blood product transfusion*
• Blood transfusion (red cell or whole blood)*
• Post-randomisation additional uterotonic agent used to control
bleeding*
• Post-randomisation additional non-surgical intervention to
control bleeding (uterine packing, bimanual uterine massage,
tamponade, external aortic compression and compression
garments)
• Admission to higher level of care*
• Side eEects of the intervention (e.g. trauma, necrosis)
• Days in hospital
• Breastfeeding (defined as any breastfeeding at hospital
discharge)*
• Maternal satisfaction with therapy (trialist defined)*
• Quality of life, including physiological activity and social and
emotional changes (sense of well-being) (trialist defined)*
Intrauterine balloon tamponade (condom-loaded catheter)
versus uterovaginal packing (intrauterine tamponade versus
another intrauterine tamponade method) (comparison 8)
One small study (Ashraf 2018) contributed data to this comparison.
The study, which involved 212 women with uncontrolled primary
PPH following vaginal birth. The study was conducted in Pakistan
and examined the use of modified condom catheter balloon
tamponade compared with uterovaginal packing for treating
primary PPH.
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Primary outcomes
Mortality due to bleeding
This outcome was not reported in the included study under this
comparison.
Hysterectomy to control bleeding
This outcome was not reported in the included study under this
comparison.
Serious maternal morbidity (renal or respiratory failure, cardiac arrest
or multiple organ failure)
This outcome was not reported in the included study under this
comparison.
Secondary outcomes
Mean blood loss (mL) (trialist defined)*
In the results section of Ashraf 2018, mean blood loss is reported
as 600.28 mL (+/- 25.33 mL) in the condom catheter group and 699
mL (+/- 70.176 mL) in the intrauterine packing group. However, it
is unclear whether this is pre- or post-randomisation, especially as
this is also presented in a table detailing participant characteristics
of each group (age, parity, gestational age, and blood loss). For this
reason, we have not included these data in our data and analysis
tables.
Side eBects of the intervention (e.g. trauma, necrosis)
Fever
Ashraf 2018 reported that the incidence of fever may be reduced
(46/106 in the condom catheter group versus 98/106 in the
intrauterine packing group) (RR 0.47, 95% CI 0.38 to 0.59, 212
women, one study, very low certainty) (Analysis 8.1), but we are
uncertain about this result because the evidence was very low
certainty .
Perforation
Ashraf 2018 reported that 30 of the 106 women in the condom
catheter group and 46 out of 106 women in the intrauterine packing
group had 'perforation' but no definition or details were provided.
We have not included these data in our data and analysis table.
Secondary outcomes not reported by the study under this comparison
The following prespecified secondary outcomes in this review were
not reported by the included study/studies under this comparison.
• All-cause mortality*
• Mortality from causes other than bleeding
• Shock as defined by trialist*
• Coagulopathy as defined by trialist*
• Number of women with total blood loss 500 mL or more aFer
randomisation*
• Number of women with total blood loss 1000 mL or more aFer
randomisation*
• Blood transfusion (red cell or whole blood)*
• Blood product transfusion*
• Post-randomisation additional uterotonic agent used to control
bleeding*
• Post-randomisation additional surgical interventions used to
control bleeding (arterial ligation, compressive, uterine sutures,
arterial embolisation, laparotomy)*
• Post-randomisation additional non-surgical intervention to
control bleeding (uterine packing, bimanual uterine massage,
tamponade, external aortic compression and compression
garments)
• Admission to higher level of care*
• Days in hospital
• Breastfeeding (defined as any breastfeeding at hospital
discharge)*
• Maternal satisfaction with therapy (trialist defined)*
• Quality of life, including physiological activity and social and
emotional changes (sense of well-being) (trialist defined)*
Modified B-Lynch compression suture versus standard B-
Lynch compression suture (one uterine compression suture
technique versus another uterine compression suture
technique) (comparison 9)
One small study (El-Sokkary 2016) contributed data to this
comparison. The study, which involved 160 women with
uncontrolled PPH following caesarean section. The study was
conducted in Egypt and examined the use of modified B-
Lynch compression sutures compared with standard B-Lynch
compression sutures for treating primary PPH.
Primary outcomes
Mortality due to bleeding
This outcome was not reported in the included study under this
comparison.
Hysterectomy to control bleeding
There is low-certainty evidence to suggest that one type of
compression suture technique (modified B-Lynch) may reduce
the incidence of hysterectomy to control bleeding (four out of
80 women) compared to another type of compression suture
technique (the classic B-Lynch technique) (12 out of 80 women)
(RR 0.33, 95% CI 0.11 to 0.99; 160 women, 1 study; low-certainty
evidence; Analysis 9.1).
Serious maternal morbidity (renal or respiratory failure, cardiac arrest
or multiple organ failure)
This outcome was not reported in the included study under this
comparison.
Secondary outcomes
Mean blood loss (mL) (trialist defined as postoperative blood loss)*
There is low-certainty evidence to suggest that the modified B-
Lynch suture technique may be associated with a reduction in
mean postoperative blood loss compared to the classic B-Lynch
technique (MD -244.00 mL, 95% CI -295.25 to -192.75; 160 women,
1 study; low-certainty evidence; Analysis 9.2).
Days in hospital
The length of time (days) that women spent in hospital was similar
between the two types of uterine compression suturing technique
(MD 0.10, 95% CI -0.38 to 0.58; 160 women, 1 study;low-certainty
evidence; Analysis 9.3).
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Secondary outcomes not reported by the study under this comparison
The following prespecified secondary outcomes in this review were
not reported by the included study/studies under this comparison.
• All-cause mortality*
• Mortality from causes other than bleeding
• Shock as defined by trialist*
• Coagulopathy as defined by trialist*
• Number of women with total blood loss 500 mL or more aFer
randomisation*
• Number of women with total blood loss 1000 mL or more aFer
randomisation*
• Blood transfusion (red cell or whole blood)*
• Blood product transfusion*
• Post-randomisation additional uterotonic agent used to control
bleeding*
• Post-randomisation additional surgical interventions used to
control bleeding (arterial ligation, compressive, uterine sutures,
arterial embolisation, laparotomy)*
• Post-randomisation additional non-surgical intervention to
control bleeding (uterine packing, bimanual uterine massage,
tamponade, external aortic compression and compression
garments)
• Admission to higher level of care*
• Side eEects of the intervention (e.g. trauma, necrosis)
• Breastfeeding (defined as any breastfeeding at hospital
discharge)*
• Maternal satisfaction with therapy (trialist defined)*
• Quality of life, including physiological activity and social and
emotional changes (sense of well-being) (trialist defined)*
D I S C U S S I O N
Summary of main results
We identified nine trials involving a total of 944 women with
primary postpartum haemorrhage (PPH) for inclusion in this
review. The trials were all small (with sample sizes ranging from
13 to 240 women) and no two studies compared the same
interventions meaning that no data meta-analysis was possible.
The trials studied a wide range of interventions including external
uterine compression (Chantrapitak 2009), arterial embolisation
versus stepwise surgical devascularisation (Farouk 2016), Bakri
balloon tamponade versus square sutures for placenta praevia
(Kavak 2013), Bakri balloon tamponade versus condom catheter
tamponade (Darwish 2018), Bakri balloon, with our without
traction suture (Khalil 2011), condom-loaded catheter tamponade
versus uterovaginal packing (Ashraf 2018), latex air-inflated balloon
tamponade plus cerclage versus normal care (Soltan 2007), two
types of B-Lynch suture (El-Sokkary 2016), and the use of a condom-
loaded Foley catheter versus normal care (Dumont 2017). There are
currently six ongoing studies; the results of these studies will be
added to this review in future updates.
It is diEicult to draw any definitive conclusions. Most of the
included studies had small sample sizes and substantial diEerences
between studies meant it was not possible to combine any trials
in meta-analysis. GRADE assessments ranged from very low to
low certainty, with the majority of results rated as very low
certainty. Downgrading decisions were mainly based on study
design limitations and imprecision. This means that we cannot be
confident about the main findings. However, in the randomised
trial by Dumont 2017, use of the condom catheter for intrauterine
tamponade in health centres in Mali and Benin was associated with
increased blood loss (very low-certainty evidence). In the Kavak
2013 study, those treated with the Bakri balloon had lower mean
blood losses both during and aFer surgery than those who had
uterine square sutures, and in the Ashraf 2018 study the condom
catheter resulted in less postpartum fever than uterine packing
with gauze (very low-certainty evidence). Finally, in the El-Sokkary
2016 study, women treated with a modified B-Lynch suture (where
the B-Lynch suture is crossed, and then also wrapped around
the proximal end of the uterus to close oE the uterine arteries)
required fewer hysterectomies to control the bleeding and had a
lower mean blood loss than those with the standard suture (low-
certainty evidence).
Overall completeness and applicability of evidence
The nine studies included in this review are of insuEicient size
and/or quality to have a major eEect on clinical practice. Most are
small, and conducted by those who have invented a new technique,
making them prone to bias. Furthermore, with only one study of
each technique, none of the trial results have been replicated and
so the results must all be treated with caution. Additionally, the use
of non-standardised outcomes in the trials also makes it diEicult
to compare studies. The scattergun nature of the studies reflects
the overall lack of a co-ordinated research strategy in this area. It
is to be hoped that as the global postpartum haemorrhage focus
moves away from uterotonics and towards quality of care, more
high-quality studies will be forthcoming.
The lack of data is not surprising as randomised trials of both
surgical techniques and devices are uncommon generally, and
especially for emergency situations where the rarity and urgency
of the situation make it logistically very diEicult to conduct
high-quality research. It is especially complex to obtain informed
consent. Recently, however, emergency intrapartum studies have
started using emergency consent procedures (COPE 2019; CORD
2018; WOMAN 2017) meaning that an abbreviated, short oral or no
consent is required before study entry. This should expand greatly
the number of high-quality randomised controlled trials conducted
in this area.
There is evidence from the studies reviewed here that will help to
direct clinical care. First, the small study by Kavak 2013 suggests
that use of the Bakri intrauterine balloon tamponade could be more
eEective than haemostatic square sutures for those with bleeding
placenta praevia. Both the intrauterine balloon tamponade and
external uterine square sutures were originally designed to treat
the atonic uterus rather than placenta praevia. In placenta praevia,
the bleeding vessels arise from the lower segment and can been
accessed directly at the time of caesarean section. The tendency
has therefore been for clinicians to use surgical sutures to compress
the bleeding vessels, rather than the more complex act of placing
a balloon vaginally during the caesarean section, inflating it within
the lower segment and closing the uterus without bursting or
trapping the balloon. Whilst the study was too small to assess
the risk of uterine scar breakdown due to balloon pressure, it
is encouraging that the authors found it eEective and usable in
practice.
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For those with a true atonic uterus at caesarean section, the study
by El-Sokkary 2016 suggests that there may be benefits to using
a modification of the B-Lynch suture in which (a) the sutures are
crossed from leF to right and vice versa as they cross the fundus,
and (b) at the end of the procedure, the ends of the suture are
passed back through the broad ligament bilaterally, around the
back of the uterus before being tied anteriorly so as to obliterate the
uterine arteries. Whilst this provides only low-certainty evidence
from a single-centre study, it does provide an intriguing alternative
for care and deserves to be tested in a further randomised trial.
Finally, the Dumont 2017 study provides surprising evidence that
the use of a condom catheter might not improve care in low- and
middle-income countries (LMICs) settings in comparison to normal
care – indeed the study found more blood loss in the condom group.
The results are very much at odds with the clinical experience
of most clinicians and implementation studies where the roll-
out of condom catheters has been associated with  impressive
improvements in severe PPH outcomes (Burke 2016). The reasons
for this discrepancy are not clear. It may be that the condom
catheter produces insuEicient intrauterine pressure (Antony 2017),
or that the time taken to set up the catheter delays care as it
allows ongoing blood loss. The increased blood loss could also have
been caused by the requirement to manually explore the uterus
prior to insertion, or by delays meaning that clotting disorders had
already commenced. However, a  step-wedge cluster-randomised
trial which was not eligible to be included in this review (Anger
2016)  supports the findings of Dumont 2017. Further studies are
now planned to determine whether it is the setting or the balloon
type that is at fault.
Quality of the evidence
Overall, the trials were of a mixed methodological quality (risk of
bias). Whilst most of the trials (7/9) used adequate methods of
sequence generation, nearly all trials (6/9) were unclear in terms of
allocation concealment. All of the trials (9/9) were at a high risk of
performance bias and detection bias was unclear in 7/9 trials and
high risk in the remaining 2/9 trials. Attrition bias was suspected in
two trials (Chantrapitak 2009; Darwish 2018), unclear in one trial
(El-Sokkary 2016) and low risk in the remaining six trials. Reporting
bias was low risk in one trial, unclear in seven trials, and high risk in
one trial (Ashraf 2018). No sources of other bias was identified in the
majority of trials (6/9), with one trial at unclear risk of other bias and
two trials assessed as being high risk of other bias (Dumont 2017;
Soltan 2007).
Our GRADE assessments of the certainty of the evidence ranged
from very low to low, with the majority of outcomes rated as
very low quality. Downgrading decisions were based on study
limitations, and imprecision (small sample sizes, few or zero
events, wide confidence intervals crossing the line of no eEect).
For one study (Soltan 2007), outcomes were also downgraded for
indirectness.
Potential biases in the review process
The strength of this review is that it only contains randomised
trials. This is particularly important in studies of postpartum
haemorrhage as spontaneous resolution of bleeding is very
common. Thus, observational studies almost always show very
high success rates, and it is not until the publication of randomised
trials that the true eEicacy is revealed. This was seen in the
randomised trials of misoprostol for PPH treatment (Geller 2006;
Mousa 2014c), and is suggested in the contrast between the cohort
studies of intrauterine balloon tamponade (Tindell 2013) and those
found in the Dumont 2017 study. The presence of randomised trials
in this diEicult area (and the future ones in progress) are therefore
very much welcomed.
This review also has weaknesses. Whilst the review processes were
robust and according to current Cochrane methodology, the study
reports did not always provide the full dataset required, and not all
authors responded to requests for further data. The review authors
have therefore had to make some assumptions about the studies'
methodologies (e.g. unclear ratings for 'Risk of bias' assessments
when no information was provided).
Agreements and disagreements with other studies or
reviews
To our knowledge, there are no systematic reviews of randomised
trials of balloon tamponade. Tindell 2013, however, reviewed the
evidence from case series and cohort studies and found a 96%
success rate with the condom catheter in LMICs. This contrasts
greatly with the findings from the Dumont 2017 study as discussed
above. However, a large step-wedged, cluster-randomised trial of
condom-balloon tamponade versus normal care was conducted
by Anger 2016. In this study, all women in the participating health
units were included, irrespective of whether they had PPH or
not. This meant that  it did not meet the inclusion criteria for the
review. It does, however, provide strong evidence that supports
the surprising findings of Dumont 2017, the only other randomised
trial  of condom-balloon tamponade. In the  Anger 2016  study,
the technique was introduced in a randomised fashion into 18
secondary-level hospitals over 18 months. AFer the introduction,
there was a significant increase in the incidence of the composite
outcome of 'PPH surgery or maternal death'  from 6.7 to 11.6 per
10,000 births, an adjusted incidence ratio of 4.08 (95% confidence
interval 1.07 to 15.58). The results are unlikely to be due to the
failure of the technique as most deaths occurred in women in whom
it was not used, but it does emphasise that PPH is a multi-system
problem and that  the condom catheter it not enough to reduce
maternal deaths from PPH on its own (Weeks 2019).
Shahin 2018 conducted a systematic review of endovascular
interventional modalities for haemorrhage control in abnormal
placentation deliveries. They included cohort and case series
in their review and most of the studies placed the devices
prophylactically prior to surgery in case of bleeding at the time
of surgery. They found that the highest success rate was with
prophylactic balloon occlusion of the abdominal aorta. These
findings were echoed by the findings of the systematic review of
Manzando-Nunez 2018 who also found the endovascular balloon
occlusion of the aorta to be highly eEective. This method was not
however addressed by any of the studies in this review.
Soro 2017 conducted a systematic review of outcomes following
arterial embolisation for PPH treatment. They found high success
rates, and no eEect on future menstrual cycle, or fertility. There was,
however higher rates than expected of abnormal placentation in
future pregnancies.
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A U T H O R S '   C O N C L U S I O N S
Implications for practice
The evidence presented in this review is generally not of high
enough quality to have major eEects on clinical practice. The
available evidence is restricted to small, single-centre studies
providing low-grade certainty evidence. However, two studies in
this review are important and could have implications for practice.
First, the study by El-Sokkary 2016 provides low-certainty evidence
that use of the modified B-Lynch suture (where the suture is
combined with uterine artery obliteration) may be superior to that
originally described. However, it was only conducted in a single
centre and without long-term follow-up to assess eEects on future
fertility. This study deserves to be repeated.
The other study of note is that of Dumont 2017, where the use of a
condom-loaded Foley catheter in two low-income African settings
led to increased rates of blood loss (very low-certainty evidence).
The findings are supported by the Anger 2016 step-wedge cluster-
randomised trial. The reason for the failures are  unclear, but
do  suggest that the global roll-out of condom catheters alone
will not  reduce mortality or morbidity from primary postpartum
haemorrhage (PPH) in these settings. The reasons for the surprising
findings are explored in Weeks 2019. They are not thought to be
necessarily a failure of the device itself, but more due to the setting
in which the technique was introduced. It is suggested that in these
settings, balloon tamponade is only introduced alongside multi-
system improvements in PPH care, including quality improvements
in blood transfusion, operating theatres and staEing.
Implications for research
High-quality randomised trials into mechanical and surgical
methods for the treatment of PPH are urgently needed. Given the
large number of deaths from PPH seen each year globally, and that
all PPH treatment pathways end with either mechanical or surgical
interventions, it is disappointing that there is so little research
in this area. The new emergency consent pathways will facilitate
recruitment, and research networks in all income settings should
consider large-scale randomised trials in which women are initially
recruited with minimal or no consent so as to compare techniques.
The findings of the Dumont 2017 are very surprising, but
supported by a large step-wedge cluster-randomised trial (Anger
2016) (excluded from this review as it included both women with
and without PPH). Whilst the use of the condom-loaded Foley used
in Dumont 2017 and Anger 2016 is an attractive low-cost option, it
may be that it is too pliable or that it takes too long to make up to be
eEective in poorer settings where surgeons commonly act alone or
with little support. Future studies could explore whether its failure
in these  studies were  due to the setting, the type of balloon, or
whether balloon tamponade is in fact an ineEective intervention.
A wide array of uterine compression sutures have been described
and, whilst appearing to be eEective in the short term, they have
been associated with future infertility and placental implantation
abnormalities. Although the study of Kavak 2013 only recruited 13
women, it shows that research is possible in this area, and that an
intrauterine balloon may be as eEective but less invasive mode of
treatment even for women with uterine bleeding during caesarean
section.
The study by El-Sokkary 2016 provides evidence that use of
the modified B-Lynch suture may be superior to that originally
described, and with minimal adverse eEects. However, it is low-
certainty evidence and the study should be repeated before
clinicians adopt the revised technique.
In high-resource settings, uterine artery embolisation has become
popular as the equipment and skills required have become more
widely available. There is little randomised trial evidence for its
eEicacy, however and its comparative clinical and cost-benefits
compared with surgical devascularisation, compression sutures or
balloon tamponade have not been established. Given its high costs
and clinical importance, this will be an important area for new
research.
Future studies could ensure that they collect minimum data for the
PPH Core Outcome set (Meher 2019) so as to facilitate future meta-
analysis.
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C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Study characteristics
Methods Randomised controlled trial
Setting: university hospital setting in Lahore, Pakistan
Participants Women (aged between 20 and 40) diagnosed with primary PPH following 'normal' vaginal birth and un-
responsive to medical treatment. There were 212 women in this study.
PPH defined as....."excessive blood loss from genital tract occurring during third stage of labour and
within first 24 hours after parturition" p 890
Gestational age >37 weeks
Women were aged 20 to 40
Exclusion criteria included PPH due to perineal, cervical or vaginal tear or episiotomy; PPH due to re-
tained placenta; vaginal birth following previous caesarean section; coagulation disorder; secondary
PPH.
Interventions Experimental: balloon (condom) tamponade - leF in place for 24 hours - 106 women
Control: uterine packing with roll gauze and vaginal packing with epipad - leF in place for 24 hours -
106 women
All women received prophylactic antibiotics (no further information given)
Outcomes • Mean blood loss (see notes below)
• Efficacy (blood loss stopped within 15 minutes of insertion and no recurrence of bleeding after re-
moval of tamponade/packing)
Ashraf 2018 
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• Safety (no infection or fever)
• Fever
• Perforation (no further information given)
Notes Trial authors' declarations of interest: "none" p892
Sources of trial funding: "none" p892
Trial dates: dates not mentioned but report states that the trial lasted for one year
Informed consent obtained?: "informed consent was obtained from each female using their data for
study purpose" p 891 (there was no mention of the women consenting to having treatment)
Ethics approval obtained?: "Given" p892
Did we attempt to contact the trial authors?: no
It is unclear what the initial 'medical treatment' was. Similarly, there is no mention of whether the
women also received usual care in addition to the interventions and, if so, what that was comprised of.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)









High risk Not mentioned. Assume neither clinicians nor participants blinded because
the intervention would look and feel different from the control group
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Not mentioned. Blood loss assessed by "counting saturated pads or by weigh-
ing sponges used to absorb blood 1mL blood weights-approx [sic] 1 blood
clots removed from uterine cavity kept in kidney tray which is, full kidney tray-




Low risk No incomplete outcome data apparent
Selective reporting (re-
porting bias)
High risk Protocol not available. Insufficient information to assess fully.
However, one outcome not detailed in Methods is reported in the Results (per-
foration).
There are very few outcomes reported, including none of those listed as im-
portant in the article background, and there is also no escalation outcomes re-
ported e.g. hysterectomy due to bleeding.
It is also unclear from the trial report whether the mean blood loss outcome
(in table 1 on p891) is pre-randomisation (participant characteristics) or post-
randomisation.
Other bias Unclear risk In the methods, it states gestational age >37 weeks and that women were aged
20 to 40. However, in the results, it states that the minimum age was 15, and
that the minimum gestational age was 36 weeks.
Ashraf 2018  (Continued)
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There is no mention of whether the women also received usual care in addi-
tion to the interventions and, if so, what that was comprised of.





Methods A parallel group randomised trial.
Setting: hospital setting in Bangkok hospital, Thailand.
Participants Women diagnosed with primary PPH following vaginal birth.
PPH was defined as "blood loss > 500ml after delivery" p 601
Gestational age 28 to 42 weeks
66 women were randomised but 2 excluded "due to cervical tear and extensive birth canal tear" p 601.
Therefore 64 women were then included in the study (32 in each group).
Interventions Experiemtal: external lower uterine compression (either by grasping the uterus through a lax abdom-
inal wall or compressing the uterus against the sacrum and lower vertebrae) for a duration of 10 min-
utes
Control: usual care consisting of "massage, oxytocin (10-20 units in 1000 ml of intravenous solution,
200 ml/min), intravenous ergometrine (Methergin®, 0.2 mg), placed cold pack on uterus, and urinary
catheterisation" p 601.
Outcomes • Measured blood loss (mL): before treatment (mean) and also after treatment (presented as medians)
• Blood transfusion
• Use of additional uterotonic agent to control bleeding (prostaglandin [Nalador])
Notes Trial authors' declarations of interest: not mentioned
Sources of trial funding: not mentioned
Trial dates: January to August 2008
Informed consent obtained?: not mentioned in the trial report
Ethics approval obtained?: not mentioned in the trial report
Did we attempt to contact the trial authors?: no
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk States that participants were "equally divided into two groups and the treat-




Unclear risk No information about allocation concealment provided in the trial report
Chantrapitak 2009 
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High risk Not mentioned but it would not be possible to blind this intervention. The pa-
per suggests that all (n = 10) blood transfusions were administered based on
haematocrit measurement, i.e. based on objective measure that would proba-
bly not be affected by lack of blinding in personnel, "Ten received blood trans-
fusion because of underlying anemia (Hct less than 33%)" (p 602). This pa-
per only reports 2 primary outcomes, volume of blood lost and blood transfu-
sion and it is possible that a lack of blinding of either participants or personnel
could have affected these outcomes and decision-making around some co-in-
terventions 
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk "Well trained nurses were assigned to record the results in the record form", p
601. Insufficient information to assess whether outcome assessors were blind-
ed. "All soaking drapes and blood in basket were weighed", p 601. Blood loss
assessed by weighing, although there could have been room for outcome as-
sessors to influence this measurement. A lack of blinding could have influ-
enced outcome assessment for blood loss (because measurement of the as-




High risk There are 2 women with cervical and vaginal tears whose outcomes are not re-
ported. It is unclear whether these were excluded before or after randomisa-
tion. However, cervical and vaginal tears are only usually found upon detailed
examination after failure of primary treatment (in this case oxytocics plus uter-
ine compression). It seems likely therefore that they were excluded AFTER ran-




Unclear risk No mention of a protocol but outcome reporting bias is not apparent





Methods Randomised controlled trial (described as single-blinded)
Setting: Assuit Women's Health Hospital, Egypt
Participants Women with primary atonic PPH following vaginal delivery and not responding to standard treatment
protocol.
PPH was not defined, and nor was there a systematic method of diagnosis (the trial report states that,
"Failure to use an accurate measure of blood loss estimation in patients and relying on indirect meth-
ods of estimation like HB before and after the intervention is a weak point of this study." p757, Darwish
2018).
Exclusions: traumatic PPH, caesarean section, placental abruption, placenta praevia, chorioamnioni-
tis, pregnancy complications (e.g. pre-eclampsia, diabetes, anaemia, rheumatic heart disease) or
women known to have coagulation problems. (Women were put under general anaesthetic before re-
cruitment into the trial, "Under general anesthesia, traumatic lesions and placental remnants were
properly excluded." p748, Darwish 2018).
100 potentially eligible women were identified but only 66 were randomised (34 refused to participate).
Mean age 28 years, mean body mass index was 27.35. Mean parity was 3.0.
Interventions Intervention: Bakri balloon (33 women)
Darwish 2018 
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"Bakri balloon is connected to a 24 French, 54 cm long silicone catheter. The Bakri balloon was well-in-
serted inside the uterine cavity. After proper positioning, the balloon was initially inflated with 150 mL
of sterile normal saline. Then the surgeon put his thumb and index finger around the cervix to keep the
partially inflated balloon above the cervix. Bakri balloon was further inflated up to 400-500 mL until the
blood draining through the catheter is considerably decreased" p 748
Control: condom-loaded Foley catheter (33 women) inflated in the same way as the Bakri balloon.
All women in both groups also received IV cephradine 1 g every 12 hours after balloon insertion.
Outcomes Primary outcome: number of women requiring surgical intervention to stop bleeding
Secondary outcomes




• Disseminated intravascular coagulopathy*
The following outcomes were reported but were not prespecified in the registration (NCT02430155)
protocol:
• Referral to ICU*
• Successful procedure
• Pulse rate, systolic and diastolic blood pressure
• Urine output
• Haemoglobin and haematocrit levels (pre/post intervention)
* These outcomes are only reported for those women who were successfully treated by balloon
tamponade, and did not include women who had treatment failure.
Notes Trial authors' declarations of interest: "The authors report no conflicts of interest" p 752.
Sources of trial funding: not mentioned.
Trial dates: October 2014 until December 2015.
Informed consent obtained?:
Ethics approval obtained?: yes, from the ethical board of the Faculty of Medicine of the Assiut Univer-
sity.
Did we attempt to contact the trial authors?: no
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Randomization was done using a computer-generated random table" p 748
Allocation concealment
(selection bias)






High risk Trial reported as single-blind but unclear who was blinded. Women were un-
der general anaesthesia so presumably effectively blinded whilst being operat-
ed on. Given the description in the study report, it is likely that personnel were
not blinded, because the interventions would clearly look different when han-
dled by clinicians. On this basis we assess this as high risk of performance bias
Darwish 2018  (Continued)
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due to likely lack of clinician blinding which could have affected clinical deci-
sion-making
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Trial reported as single-blind but unclear who was blinded; no mention of
blinding of outcome assessors in trial report. It is possible that non-indepen-




High risk Data on use of blood transfusion, intensive care unit referral and coagulopathy
were not reported for those who had 'treatment failures' in each group. Rather




Unclear risk Trial was registered NCT02430155 but checking the outcomes in the protocol
against the trial report there are some differences. We note that the following
reported outcomes were not listed in the study protocol: referral to intensive
care unit, successful procedure, pulse rate, systolic and diastolic blood pres-
sure, urine output, haemoglobin and haematocrit levels (pre/post interven-
tion)





Methods Randomised controlled trial (multi-centre, 2 parallel groups)
Setting: 7 healthcare facilities in Cotonou, Benin and Bamko, Mail.
Participants 116 women diagnosed with primary PPH following vaginal birth. Women were suspected to have PPH
due to clinical atony and who were quote: "unresponsive to oxytocin and who needed additional utero-
tonics" p 1
PPH was defined as quote: "visual estimation of excessive blood loss and patient status (blood pres-
sure and cardiac frequency)" p 2
Exclusions: uterine rupture or placenta accreta
Interventions Intervention: uterine balloon tamponade plus normal care (misoprostol) (57 women). In the balloon
tamponade group, a condom-loaded Foley catheter was inflated "by increments of 250 mL of solute" p
2. Further Increments were added (up to a maximum of 1000 mL) if bleeding was still evident 5 minutes
after adding the solution.
Control: normal care (misoprostol) (59 women)
All women received rectal misoprostol (1000 ug) or sublingually (600 ug) following randomisation.
Although the report states in the methods p2 that, "In all cases, a single dose of cefazolin or ampicillin
was administered as an antibiotic prophylaxis", in the results it reports only 15/57 vs 15/59 also re-
ceived antibiotics (table 2, drug and dose not described).
Outcomes Composite main outcome of recourse to invasive surgery (arterial ligatures, uterine compression su-
tures, hysterectomy) or death before hospital discharge
Secondary outcomes
• Artery ligations
• Uterine compressive sutures
Dumont 2017 
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• Hysterectomy
• Transfer to intensive care unit
• Total blood loss more than 1000 mL
• Maternal death
Notes Trials registration: ISRCT Registry Number 01202389 post-results
Sources of trial funding: Research Institute for Development (IRD) and United Nations Children's Fund
(UNICEF)
Trial authors' declarations of interest: all authors quote: "declare no relationships or activities that
could appear to have influenced the submitted work" p 8
Trial dates: May 2013 to December 2015
Informed consent obtained?: trial report states "obtained" (p 8)
Ethics approval obtained?: Yes - "Ethics and Research Committee of the Institute of the Biomedical
Applied Sciences of Benin; Ethic Committee of the Research Institute for Development of France" p 8
Did we attempt to contact the trial authors?: no
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Quote: "A computer-generated randomisation sequence was generated by the
principal investigator (AD) and stratified by health centre. Within the strata,
women with PPH which was not controlled by the first-line therapy were indi-
vidually allocated by blocks randomisation (varying blocks of four and strati-
fied by healthcare centre)"
Judgement comment: "Computer generated random sequence generation...
stratified by health centre... block randomisation" p 3
Allocation concealment
(selection bias)
High risk Judgement comment: there is no evidence that the allocation was concealed
to the trial supervisor - and it was he/she that decided over the phone whether
to randomise or not. The fact that there was a 'randomisation code' known to
4 people suggests that this was a revealed list. This trial also randomised in
blocks of 4, stratified by centre. If any staE in local centres were aware of the






High risk Not mentioned but assume that blinding not possible because only 1 group re-
ceived mechanical intervention.
The role of visual estimation suggests a lack of personnel blinding could have
affected clinical decision-making based on diagnosis of volume of blood lost
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Blinding of the outcome assessors is not mentioned. It is possible that non-in-
dependent blinded providers have biased the outcomes assessments. Report
states that "Since the use of collection bag is not common practice in Benin
and Mali, PPH was clinically assessed by the caregivers (midwife or doctor) ac-
cording to the visual estimation of blood loss and patient status (blood pres-
sure and cardiac frequency)" p 2 Dumont 2017. It is not clear whether these
particular caregivers were blinded although given the nature of the interven-
tion it seems unlikely. It is also unclear whether any attempt was made to
blind assessors for most other outcomes or clinical decisions (except maternal
death: "Each maternal death was audited by two independent experts in order
to assess if the event was possibly due to the experimental treatment or not" p
3 Dumont 2017).
Dumont 2017  (Continued)
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Low risk All those excluded were excluded prior to randomisation, and data reporting
appears to be otherwise complete
Selective reporting (re-
porting bias)
Low risk Quote: "SRCT Registry Number 01202389
Quote: "The primary outcome is a composite outcome. It corresponds to the
proportion of women with recourse to an invasive surgery (arterial ligatures,
uterine compressive sutures, hysterectomy) or who died before hospital dis-
charge. The secondary outcomes were each component of the composite out-
come and also total blood loss more than 1000 mL, blood transfusion and
transfer to intensive care unit."
Judgement comment: the ISRCTN Entry states: the primary outcome is a com-
posite outcome: individual recourse to an invasive surgery (arterial ligatures,
uterine compressive sutures, hysterectomy of haemostasis) and/or maternal
death before the hospital release. Secondary outcome measures: each ele-
ment of the composite primary outcome is related to the point 1 and 2 only. So
the secondary outcomes are formed by the 2 elements of the primary outcome
measured separately and we will also measure 3 other outcomes: bleedings
> 1000 mL, necessity of a transfusion, necessity of a transfer. 1. Invasive inter-
vention rate (arterial ligatures, uterine compressive sutures or hysterectomy
of haemostasis): number of women having received an invasive intervention
divided by the number of women included 2. Hospital maternal mortality rate
(number of women included in the study and died before the hospital release
divided by the number of inclusive women) 3. Bleeding > 1000 mL. 4. Necessi-
ty of a transfusion 5. Necessity of a transfer The only differences are that 'hys-
terectomy for haemostasis' in the protocol has been changed to 'hysterecto-
my'; and the outcome of 'transfer' has been changed to 'transfer to intensive
care unit'. We think that these are very minor and so classify this as 'low risk' of
bias.
Other bias High risk Many women did not receive treatment per trial protocol, either due to delays
in the steps of the diagnosis or administration of treatment, or not receiving
the allocated intervention at all. Prior to randomisation, 25% of women in in-
tervention group and 21% in control did not receive oxytocin within 10 min-
utes of diagnosis of PPH. Two of the women who died in the tamponade arm
did not receive the device because they died before the procedure. Two oth-
er women did not receive the device because staE decided to postpone using
it for unknown reasons. 42% of women in the intervention group received the
UBT more than 30 min after PPH diagnosis. Table 2 in Dumont 2017 states that
all women did in fact receive misoprostol as standard second-line care, but it
was administered late (more than 30 minutes after PPH diagnosis) to 54% in
intervention group and 37% in the control group. We do however note that on
p6 of this paper, the trial authors state that one women died (case 5) before
misoprostol was administered.





Methods Randomised controlled trial
Setting: Department of Obstetrics and Gynecology, Ain Shams University Hospital, Cairo, Egypt.
El-Sokkary 2016 
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Participants 160 women with uncontrolled atonic PPH following caesarean section, and not responding to standard
care (uterine massage, uterotonics and bimanual compression).
Exclusions: traumatic PPH, disseminated intravascular coagulopathy, bleeding diathesis, retained pla-
centa, uterine anomalies.
PPH not defined
Interventions Intervention: modified B-Lynch compression suture (80 women) using a technique whereby the
sutures are placed in the shape of the figure 8, and then threaded through the broad ligament and
wrapped around the lower part of the uterus to obliterate the uterine arteries bilaterally.
Control: standard B-Lynch compression suture (80 women)
Outcomes • Successful (bleeding stopped and no need for hysterectomy)
• Unsuccessful (bleeding continued and need for hysterectomy)
• Postoperative blood loss
• Need for hysterectomy
• Need for blood transfusion
• Hospital stay
• Duration of the procedure
• Preoperative Hb
• Postoperative Hb





Notes Trial authors' declarations of interest: the authors reported that they had no completing interests
Sources of trial funding: none declared
Trial dates: January 2013 to October 2015
Informed consent obtained?: "Consent for publication = not applicable" - no mention of informed
consent for participants.
Ethics approval obtained?: "The study was conducted in accordance with the guidelines of the Decla-
ration of Helsinki and was approved by the Institutional Review Board (IRB) of Ain Shams Mater Univer-
sity" p 5
Did we attempt to contact the trial authors?: email to authors on 25 Aug 2018 requesting further
information on blood transfusion and sequential numbering of trial envelopes - response from El-
Sokkary on 25 Aug 2018 requesting joint authorship of the Cochrane Review in order to provide this in-
formation. Explained that this was not possible. No further response received as of 07 Sep 2018.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Computer generated list of random numbers was kept in Ain Shams Maternity
Hospital computer and with research supervisors" (p 2)
Allocation concealment
(selection bias)
Unclear risk "Computer-generated randomised series were kept in sealed envelopes"
Comment: does not state whether the envelopes were consecutively num-
bered or opaque
El-Sokkary 2016  (Continued)
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High risk Not mentioned. Women were under general anaesthesia during intervention.
Assume blinding of surgical personnel not possible due to difference in inter-
vention techniques between groups
Blinding of outcome as-
sessment (detection bias)
All outcomes




Unclear risk Table 1 (data) does not state number of women. No incomplete data were
mentioned in the text but 1 cannot assume that outcome data are complete
Selective reporting (re-
porting bias)
Unclear risk Protocol not available - insufficient information to permit assessment





Methods Randomised controlled trial
Setting: Ain-Shams University Maternity Hospital, Egypt
Participants 24 women with primary PPH (blood loss more than 1000 mL) within 2 hours of birth and not responding
to first-line treatment. The majority of women (more than 70% in both groups) had primary atonic PPH,
the remainder of the women had PPH due to lacerations or bleeding at the placental site.
Exclusion criteria: "history of coagulopathy, thrombocytopenia or anticoagulant therapy, HELLP syn-
drome or eclampsia, impaired serum creatinine, and mental conditions rendering the patient unable to
understand the nature, scope and possible consequences of the study" p 818
Interventions Intervention: uterine arterial embolisation (11 women - 1 other women refused to have UAE). Of the 11
randomised, 9 had vaginal delivery and 2 had caesarean section.
"The procedures were done under fluoroscopic control using monoplane cath-laboratory unit (Toshi-
ba-Japan) with a 5Fsheath (TERUMO) and a 5F Cobra2 catheter (Cordis) with a 0.35F hydrophilic guide
wire (TERUMO). The sheaths were leF in place for 24 hours and the patients were transferred to the
ICU." p 818
Control: "emergency laparotomy for stepwise devascularisation and compression sutures" p 818 (12
women). Of the 12 women, 8 had vaginal delivery and 4 had caesarean section.
Outcomes • Cessation of bleeding
• Hysterectomy due to bleeding
• Postpartum fever (temperature > 38.5 deg C)
• Complications
Notes Trial authors' declarations of interest: "we have no conflicts of interest to declare" p 823
Sources of trial funding: not mentioned
Trial dates: May 2011 until May 2013
Farouk 2016 
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Informed consent obtained?: "Approval was obtained from the ethical committee of the department
of Obstetrics and Gynecology, Ain-Shams University" p 818
Ethics approval obtained?: yes - "oral consent was obtained from each participant before proceeding
to either of the options" p818
Did we attempt to contact the trial authors?: no
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "The patients were randomized using a computer-generated list (MedCalc ver-




Unclear risk "The randomization protocol was also concealed using closed envelopes so
that each envelope contained the name of one of the 2 options" (p 818)






High risk Not mentioned. Assume blinding of personnel not possible due to difference in
intervention techniques between groups
Blinding of outcome as-
sessment (detection bias)
All outcomes








Unclear risk Protocol not available





Methods "Randomised prospective single blind trial" (p 706)
Setting: university hospital setting in Turkey
Participants Women with complete placenta praevia and intractable bleeding (n = 13) following caesarean section.
PPH was not defined.
Exclusions: serious medical, haematological or surgical diseases; placental implantation anomalies
such as placenta accreta/increta/percreta; history of thromboembolism; emergency CS; macrosomia;
poly -hydramnios; preeclampsia; gestational diabetes; intrauterine growth retardation; and presence
of multiple gestations.
Interventions Intervention: Bakri balloon tamponade intraoperatively through uterine incision (7 women) - was in-
flated with saline (100 mL to 200 mL) "according to the uterine size" p 706
Kavak 2013 
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Control: Endouterine haemostatic square suturing to the lower segment of the uterus (6 women). 4-5
sutures were applied.
All women were given prophylactic antibiotics.
Outcomes • Blood loss in the first 24 hours
• Operative time
• Hb pre and post operation
• Intraoperative blood loss
• Blood transfusion
• Postoperative blood loss
Notes Trial authors' declarations of interest: the authors state that they have no conflicts of interest.
Sources of trial funding: not reported.
Trial dates: August 2011 to August 2012
Informed consent obtained? yes
Ethics approval obtained? yes, from the local research ethics committee
Did we attempt to contact the trial authors?: email to Dr Kavak on 25 Aug 2018 requesting data on
blood loss following transfusion only (not total blood loss). No response as of 1 March 2019.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Trial report states "randomly divided" - insufficient information provided
Allocation concealment
(selection bias)





High risk Reported to be a single-blind trial but no further information explicitly provid-
ed, although women were under general anaesthesia so presumably effective-
ly blinded whilst undergoing intervention.
Assume blinding of surgical personnel not possible due to difference in inter-
vention techniques between groups.
(Blood loss during the operation calculated by the anaesthetist (evaluation of
blood collected via suction plus weighing of absorbant pads) - reasonably ob-
jective. During first 24 hours, postoperative blood loss measured by weighing
pads worn by patients - again, this is reasonably objective so we question the
extent to which lack of blinding would matter - it may have had lots of small
impacts on clinical decision-making)
Blinding of outcome as-
sessment (detection bias)
All outcomes





Low risk No missing outcome data
Selective reporting (re-
porting bias)
Unclear risk No protocol available
Kavak 2013  (Continued)
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Methods Randomised controlled trial
Setting: security forces hospital, Riyadh, Saudi Arabia
Participants Women with uncontrolled primary atonic PPH during caesarean section and not responding to stan-
dard treatment (standard treatment not described).
PPH was not defined.
Exclusions: < 28 weeks' gestation
Traumatic bleeding or placenta praevia
Interventions Intervention: Bakri balloon inserted intraoperatively through uterine incision, then secured with trac-
tion stitch (25 women). "Bakri balloon was fixed with nylon loop stitching through the hole of its proxi-
mal shaF, and the needle was then passed through the uterine cavity and the anterior abdominal wall.
The thread was fixed to the skin to keep the balloon within the uterine cavity without any additional
packing or the insertion of a balloon vaginally" p 198.
Control: Bakri balloon intraoperatively through uterine incision, without traction stitch (25 women)
Both groups of women received intravenous antibiotics for the first 48 hours and oxytocin infusion for
the first 8 hours.
It is not clear how much saline was used to inflate the balloons...the trial report states that, "the bal-
loon was inflated until it conformed to the contour of the uterus in order to provide a symmetric tam-
ponade effect" p 198
Outcomes • Displacement of Bakri balloon
• Bleeding after displacement of balloon
• Blood loss (estimated)
• Hysterectomy
• Other surgical intervention needed
• Bleeding after deflation of the balloon
Notes The study was stopped after 50 cases because there was a high rate of Bakri balloon displacement in
the control group.
Trial authors' declarations of interest: "the authors have no conflicts of interest" p 199
Sources of trial funding: not reported
Trial dates: 1 April 2004 and 30 April 2009
Ethical approval? "the hospital ethics committee approved the study" p198
Informed consent? yes, "informed consent was obtained from all participants" p 198
Contacted trial authors?: yes, email to Dr Khalil on 25 Aug 2018 requesting data on dichotomous
blood loss outcomes. Data sent to ADW on 06 Sep 2018.
Risk of bias
Khalil 2011 
Mechanical and surgical interventions for treating primary postpartum haemorrhage (Review)









Cochrane Database of Systematic Reviews
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Computer-based random sampling" p 198
Allocation concealment
(selection bias)





High risk Blinding not mentioned. Assume blinding of personnel not possible due to dif-
ference in intervention techniques between groups
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk No incomplete outcome data
Selective reporting (re-
porting bias)
Unclear risk Protocol not available. Insufficient information to make an assessment of re-
porting bias





Methods Randomised controlled trial
The trial report says it is a "Randomized clinical trial/cross over study" (in the abstract only). Although
some members of the control group do receive the intervention, the methods described in the report
are not those of a cross-over trial; the fact that the women in the control group received the interven-
tion was not 'designed in': according to their methods it does not seem to be pre-specified in the trial
design.
Setting: Beni-Mazar District Hospital, El-Menia, Egypt
Participants 240 women with PPH, due to atony, following vaginal birth at home or in hospital
PPH is not defined in the trial report, and there is no information on how blood loss was assessed.
Exclusions: "cases of PPH due to traumatic, retained placental tissues, other cause and after cesarean
delivery" p54
Interventions Intervention: woman received the 'El-Menia' balloon plus cervical stitch to "prevent herniation of the
inflated balloon through the dilated cervix" (p54), plus standard care (see below). The El-Menia balloon
tamponade consists of an orange latex party balloon (0.19 mm thick) attached to a 15 cm long Nel-
ton catheter. The balloon was inflated with air using a sphygmomanometer to 140 mmHg and then at-
tached to the catheter using silk suture "tied over tightly several times... to prevent air escape" P54. To
keep the balloon in place, cervical cerclage was applied ("at 3 and 9 o'clock" p54). Women in this group
also received antibiotic prophylaxis: gentamycin 80 mg, metronidazole 500 mg, and ampicillin 500 mg,
immediately after the balloon was inserted and every 8 hours thereafter for the subsequent three days.
(120 women)
Soltan 2007 
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Control: standard care - "women were treated with uterine massage and ecbolics according to WHO
protocol" p 54 (120 women)
Women receiving the intervention were also given metronidazole 500 mg, gentamycin 80 mg, and
ampicillin 500 mg after insertion of the balloon, every 8 hours for 3 days.








• Unit of syntocinon used
• Ampules of ergometrine used
• Units of blood transfused
• Haemaglobin on discharge
• Haematocrit on discharge
• Time (hours) to resuscitate
• Time (hours) to regain normal uterine tone
• Days stay in intensive care unit
• Days stay in hospital
Notes Trial authors' declarations of interest: not reported
Sources of trial funding: not reported
Trial dates: 2003 to 2004 (precise date not given)
Ethical approval? yes "the study design was approved by El-Menia Faculty of medicine ethical com-
mittee" p54
Informed consent? Women were admitted to the study after their husbands gave informed consent
Contacted trial authors? Yes. We attempted to email Professor Soltan on 20 January 2020 but did not
receive a reply.
The trial methods specified that all women in the control group would receive standard care as the
first-line treatment. However, 19/120 women in the control group subsequently received UBT as a sec-
ond-line treatment. The authors preserved intention-to-treat (those 19 women remained in the control
group).
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation (no further details provided)
Allocation concealment
(selection bias)





High risk Blinding not mentioned. Assume blinding of personnel not possible due to dif-
ference in intervention techniques between groups
Soltan 2007  (Continued)
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Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk No incomplete outcome data apparent
Selective reporting (re-
porting bias)
Unclear risk Protocol not available. Insufficient information to make an assessment of re-
porting bias
Other bias High risk 19 women in the control group also received the intervention as a second-line
treatment. This secondary use of UBT was not prespecified in the methods. No
other sources of bias were apparent
Soltan 2007  (Continued)
Hb: haemoglobin; ICU: intensive care unit; PPH: postpartum haemorrhage; UBT: uterine balloon tamponade.
 
Characteristics of excluded studies [ordered by year]
 
Study Reason for exclusion
Soltan 2009 Quasi-RCT (alternate allocation)
Soltan 2010 Quasi-RCT (alternate allocation)
Gelany 2012 This is an abstract for a PPH treatment study but there is insufficient information to permit 'Risk of
bias' assessment.
Letouzey 2013 Study terminated due to recruitment difficulties.
Mohamed 2014 Abstract with insufficient information to assess risk of bias.
Khalil 2014 Abstract with insufficient information to assess risk of bias. Query whether this is report of Khalil
2011 but the limited outcome data do not match. Contacted trial author by email - he replied con-
firming that this study is separate to Khalil 2011 trial.
Nermeen 2015 Prevention of PPH study
Rahman 2015 This was a trial of TempostatTM - a self-regulating tamponade device for management of postpar-
tum haemorrhage (see NCT02416089). The trial was terminated.
Purwosonu 2015 Not an RCT. This is an open-label non-randomised trial
Rezk 2016 Prevention of PPH study
Anger 2016 This step-wedge cluster-RCT looked at a policy of introducing UBT into routine practice.  18 hospi-
tals were randomised and the participants included women with PPH and without PPH.  We have
excluded this study because (1) it does not meet the inclusion criteria; and (2) does not give a sensi-
tivity analysis of PPH women that could have been included. 
von Beckerath 2016 Abstract with insufficient information to permit 'Risk of bias' assessment. We query whether this is
part of Ali 2015a (ongoing) - we have contacted the authors for clarification.
Liu 2016 Not a PPH treatment RCT - comparison of 2 different nursing methods for women who had all had
uterine embolisation for PPH
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Study Reason for exclusion
Azmy 2016 Prevention of PPH study
Chen 2017 Prevention of PPH study
Sallam 2019 Prevention of PPH study
Farouk 2018 Prevention of PPH study
PPH: postpartum haemorrhage;RCT: randomised controlled trial; UBT: uterine balloon tamponade.
 
Characteristics of studies awaiting classification [ordered by study ID]
 
Methods Randomised trial - open-label - 2 arms
Participants 66 women enrolled. Women (aged 20 to 40) with primary PPH (due to atony)
Exclusions: traumatic PPH
Interventions Celox haemostatic dressings
versus
Bakri balloon
Outcomes Blood loss (mL)
Notes Completion date listed as October 2015. Status listed as 'completed'.
NCT0256857
Mohammed Khairy Ali, Assuit University
No email contact listed in trial registration but we found the trial author's contact details from the





Methods Prospective randomised trial - 3 arms - open-label
Participants 150 women with PPH (due to atony) but "not indicated for surgical intervention"
Ages 18 to 45, vaginal birth or caesarean section
Exclusions: genital tract laceration, uterine rupture, retained placenta, known blood coagulation
issues.
Interventions Bakri Balloon alone
Bakri balloon and intrauterine misoprostol wash
Control group = a further group 'treated conservatively' - ecobolic
Outcomes Primary
Elkateeb 2016 
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• Blood transfusion





• Duration of ICU admission
• Duration of hospital stay
Notes PACTR201601001435165
Funding source: Minia Maternity Hospital, Egypt
Recruitment status: completed
Sources of trial funding: trial sponsored by Minia Maternity Hospital, and Faculty of Medicine, Minia
(both in Egypt)
Ethical approval obtained? No (was due to be submitted for ethical approval on 1 Feb 2016, date of
approval is blank)
Contacts: principal investigator: Reham Elkateeb (rehamelkhateeb78@yahoo.com); public en-
quiries: Hossam Shawki (hossam200002003@yahoo.com); scientific enquiries to Ahmad Mahran
(ezzeldin_ahmad@yahoo.com)
Emailed study authors on 7 November 2019, awaiting a reply.
Elkateeb 2016  (Continued)
Hb: haemoglobin;ICU: intensive care unit; PPH: postpartum haemorrhage.
 
Characteristics of ongoing studies [ordered by study ID]
 
Study name Bakri balloon with or without abdominal traction stitch in management of uterine bleeding in cas-
es of placenta praevia
Methods RCT - single blind - 2 arms
Participants Women with primary PPH (atony)
Exclusions: traumatic PPH, uterine infection (suspected or confirmed); pre-eclampsia, gestation-
al diabetes; deep vein thrombosis or other thromboembolic complications; history of rheumatic
heart disease; coagulopathy.
Interventions Intervention:Bakri balloon with abdominal traction stitch
Control: Bakri balloon without abdominal traction stitch
Outcomes Failure of Bakri balloon (balloon rupture or slippage [24-hour timeframe])
Starting date March 2016 but as at 7 November 2019 the study is listed 'not yet recruiting'
Contact information Ahmed Mohamed Abbas, Assuit University, Egypt
No email address listed
Notes NCT02694341
Abbas 2016 
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Funding source: not mentioned
Recruitment status: not yet recruiting




Study name STUT study
Uterine vacuum tamponade for treatment of postpartum haemorrhage: a randomized study
Methods RCT
Participants Women (over 18 years of age) with PPH
Exclusions: PPH due to cervical/vaginal tears
Plan to include 84 participants
Interventions Suction tube uterine tamponade
Standard care control
Outcomes Primary
• Measured blood loss within 60 minutes after enrolment >median for the control group (lognormal
distribution comparison), or operative procedures (e.g. laparotomy, hysterectomy) or death
Secondary
• Mean blood loss within 60 minutes after enrolment
• Blood loss within 60 minutes after enrolment > 500 mL (lognormal distribution comparison) or
operative procedures (e.g. laparotomy, hysterectomy) or death
• Blood pressure, pulse and shock index 10 minutes after enrolment
• Change in Hb levels pre- delivery to post delivery
• Blood transfusion or death;
• ICU admission or death
• Death
Starting date 1 August 2019 (planned)
Contact information Justus Hofmeyr (justhof@gmail.com) - Principal investigator
Notes PACTR201907769424884
Funding source: trial sponsored by the University of Witwatersrand, South Africa
Recruitment status: not yet recruiting
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Study name The comparative study to evaluate the success rate of the intrauterine tamponade balloon and
gauze packing the event of uncontrollable haemorrhage due to placenta praevia in caesarean sec-
tion cases: a randomised prospective controlled multicenter trial
Methods Prospective RCT - 2 arms
Participants 204 women with PPH following caesarean section and placenta praevia. Term gestation >/= 28
weeks).
Exclusion: praevia accreta; uterine infection; 'others'?
Age between 18 and 50
Interventions Intrauterine inflated balloon
Gauze packing
Outcomes Primary
• Rate of haemostasis
• Mean blood loss over 24 hours
• Intrauterine infection
• Postoperative pain score
Secondary
• Puerperium complication
Starting date Study dates were planned to be 1 June 2015 until 31 December 2017
Contact information Jing Wei qlm_weijin@163.com (applicant)








Study name Does cold saline used to inflate a balloon tamponade catheter more significantly reduce blood loss
from postpartum haemorrhage than room temperature saline?
Methods Randomised trial - open-label - 2 arms
Participants 50 women aged 18 to 45 with PPH following vaginal birth
Exclusions: women outside age range
Interventions Cold Bakri balloon (filled with saline at 32 deg F)
Room temperature Bakri balloon (filled with saline at room temperature)
Outcomes Primary
Joshipura 2016 
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Total blood loss
Starting date  
Contact information Swati B Joshipura swati.joshipura@bswhealth.org
Jack Stecher jack.stecher@bswhealth.org
Notes NCT02735733
Protocol - status as at 7 November is 'not yet recruiting'
But estimated completion time was June 2016




Study name A comparative study between Bakri balloon and B-Lynch suture used to control primary postpar-
tum haemorrhage after caesarean section
Methods RCT - parallel - open-label
Participants Women aged between 18 to 40 years of age undergoing elective caesarean section and having
atonic PPH
Exclusions: PPH following vaginal delivery; secondary PPH; PPH due to causes other than atony;
antepartum haemorrhage; tendency towards bleeding; other caesarean section complication (e.g.
bladder injury, DIC).




• Blood loss during the procedure (calculation will include "number of saturated pads + amount in
suction container + visualization by the operating team")
Starting date March 2019
Contact information Ahmed Maged - profahmedmaged@gmail.com - principal investigator
Cairo University
Notes NCT03891082
Expected completion: December 2019
Status listed as 'not yet recruiting' as at 7 November 2019
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Study name Assessment of the efficacy of early intrauterine tamponade with a belfort-dildy balloon obstetric
tamponande system in the treatment of immediate postpartum haemorrhage
Methods RCT - open-label
Participants Belfort-Dildy balloon device plus intravenous sulprostone infusion
intravenous sulprostone infusion
Estimate 430 women
Interventions Blood loss in first 24 hours greater than or equal to 1500 mL
Blood transfusion
Blood products transfusion
Other markers of severe haemorrhage (Hg change; haematocrit; etc)
Genital tract infection
Fever
Endometritis during postpartum hospitalisation
Maternal death postpartum
Outcomes Need for invasive procedure (embolisation/surgery) due to PPH
Starting date April 2016
Contact information Patrick Rozenberg prozenberg@chi-poissy-st-germain.fr
Laurence Lecomte laurence.lecomte@nck.aphp.fr
Notes NCT02226731
Sponsor: Assistance Publique - Hopital de Paris
Status: recruiting (as at 7 November 2019)
Rozenberg 2014 
DIC: disseminated intravascular coagulation;Hb: haemoglobin; ICU: intensive care unit; IPD: individual patient data; PPH: postpartum
haemorrhage; RCT: randomised controlled trial.
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   External lower uterine compression versus normal care





Statistical method Effect size
1.1 Blood transfusion (red cell or whole blood) 1 64 Risk Ratio (M-H, Fixed, 95% CI) 2.33 [0.66, 8.23]
1.2 Post-randomisation additional uterotonic agent
used to control bleeding
1 64 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.12, 3.73]
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Analysis 1.1.   Comparison 1: External lower uterine compression versus






Test for overall effect: Z = 1.32 (P = 0.19)



















M-H, Fixed, 95% CI
2.33 [0.66 , 8.23]
2.33 [0.66 , 8.23]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours uterine compress Favours standard care
 
 
Analysis 1.2.   Comparison 1: External lower uterine compression versus normal care,






Test for overall effect: Z = 0.46 (P = 0.64)



















M-H, Fixed, 95% CI
0.67 [0.12 , 3.73]
0.67 [0.12 , 3.73]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours uterine compress Favours standard care
Footnotes
(1) Prostaglandin (Nalador) due to uncontrollable bleeding after oxytocin and Methergin
 
 
Comparison 2.   Uterine arterial embolisation versus surgical devascularisation plus B-Lynch (one uterine
devascularisation technique versus another uterine devascularisation technique)





Statistical method Effect size
2.1 Hysterectomy to control bleeding 1 23 Risk Ratio (M-H, Fixed, 95% CI) 0.73 [0.15, 3.57]
2.2 Side effects of the intervention (e.g. trauma,
necrosis)
1 23 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.08, 15.41]
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Analysis 2.1.   Comparison 2: Uterine arterial embolisation versus surgical
devascularisation plus B-Lynch (one uterine devascularisation technique versus another






Test for overall effect: Z = 0.39 (P = 0.69)



















M-H, Fixed, 95% CI
0.73 [0.15 , 3.57]
0.73 [0.15 , 3.57]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Uterine art embolisation Surgical devasc + B-Lynch
 
 
Analysis 2.2.   Comparison 2: Uterine arterial embolisation versus surgical devascularisation
plus B-Lynch (one uterine devascularisation technique versus another uterine devascularisation






Test for overall effect: Z = 0.06 (P = 0.95)



















M-H, Fixed, 95% CI
1.09 [0.08 , 15.41]
1.09 [0.08 , 15.41]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Uterine art embolisation Surgical devasc + B-Lynch
 
 
Comparison 3.   Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol)





Statistical method Effect size
3.1 Mortality due to bleeding 1 116 Risk Ratio (M-H, Fixed, 95% CI) 6.21 [0.77, 49.98]
3.2 Hysterectomy to control bleeding 1 116 Risk Ratio (M-H, Fixed, 95% CI) 4.14 [0.48, 35.93]
3.3 All cause mortality 1 116 Risk Ratio (M-H, Fixed, 95% CI) 6.21 [0.77, 49.98]
3.4 Mortality from causes other than bleeding 1 116 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3.5 Number of women with total blood loss 1000
mL or more after randomisation
1 113 Risk Ratio (M-H, Fixed, 95% CI) 1.52 [1.15, 2.00]
3.6 Blood transfusion (red cell or whole blood) 1 116 Risk Ratio (M-H, Fixed, 95% CI) 1.49 [0.88, 2.51]
3.7 Post-randomisation additional surgical inter-
ventions used to control bleeding (arterial liga-
tion, compressive, uterine sutures, arterial em-
bolisation, laparotomy)
1   Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.7.1 Uterine compression sutures 1 116 Risk Ratio (M-H, Fixed, 95% CI) 5.17 [0.25,
105.44]
3.7.2 Artery ligation 1 116 Risk Ratio (M-H, Fixed, 95% CI) 1.38 [0.32, 5.90]
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Statistical method Effect size
3.8 Admission to higher level of care 1 116 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [0.55, 3.04]
3.9 Side effects of the intervention (e.g. trauma,
necrosis)
1   Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.9.1 Severe shivering, diarrhoea, vomiting or
high temperature
1 116 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
 
 
Analysis 3.1.   Comparison 3: Intrauterine balloon tamponade plus normal care






Test for overall effect: Z = 1.72 (P = 0.09)



















M-H, Fixed, 95% CI
6.21 [0.77 , 49.98]
6.21 [0.77 , 49.98]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours uterine balloon Favours standard care
 
 
Analysis 3.2.   Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol)






Test for overall effect: Z = 1.29 (P = 0.20)



















M-H, Fixed, 95% CI
4.14 [0.48 , 35.93]
4.14 [0.48 , 35.93]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours uterine balloon Favours standard care
 
 
Analysis 3.3.   Comparison 3: Intrauterine balloon tamponade plus normal care






Test for overall effect: Z = 1.72 (P = 0.09)



















M-H, Fixed, 95% CI
6.21 [0.77 , 49.98]
6.21 [0.77 , 49.98]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours uterine balloon Favours standard care
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Analysis 3.4.   Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol)






Test for overall effect: Not applicable





















M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours uterine balloon Favours standard care
 
 
Analysis 3.5.   Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal






Test for overall effect: Z = 2.94 (P = 0.003)



















M-H, Fixed, 95% CI
1.52 [1.15 , 2.00]
1.52 [1.15 , 2.00]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours uterine balloon Favours standard care
Footnotes
(1) Note: this is total blood loss postnatally - not post-randomisation
 
 
Analysis 3.6.   Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol)






Test for overall effect: Z = 1.49 (P = 0.14)



















M-H, Fixed, 95% CI
1.49 [0.88 , 2.51]
1.49 [0.88 , 2.51]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours uterine balloon Favours standard care
 
 
Mechanical and surgical interventions for treating primary postpartum haemorrhage (Review)









Cochrane Database of Systematic Reviews
Analysis 3.7.   Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus
normal care (misoprostol), Outcome 7: Post-randomisation additional surgical interventions used to
control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)
Study or Subgroup











Test for overall effect: Z = 0.43 (P = 0.66)





























M-H, Fixed, 95% CI
5.17 [0.25 , 105.44]
5.17 [0.25 , 105.44]
1.38 [0.32 , 5.90]
1.38 [0.32 , 5.90]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours uterine balloon Favours standard care
 
 
Analysis 3.8.   Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol)






Test for overall effect: Z = 0.59 (P = 0.56)



















M-H, Fixed, 95% CI
1.29 [0.55 , 3.04]
1.29 [0.55 , 3.04]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours uterine balloon Favours standard care
 
 
Analysis 3.9.   Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus
normal care (misoprostol), Outcome 9: Side eBects of the intervention (e.g. trauma, necrosis)
Study or Subgroup





Test for overall effect: Not applicable





















M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours uterine balloon Favours standard care
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Comparison 4.   Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine
tamponade versus normal care)





Statistical method Effect size
4.1 Mortality due to bleeding 1 240 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
4.2 Hysterectomy to control bleeding 1 240 Risk Ratio (M-H, Fixed, 95% CI) 0.14 [0.01, 2.74]
4.3 All-case mortality 1 240 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
4.4 Mortality from causes other than bleed-
ing
1 240 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
4.5 Days in hospital 1 240 Mean Difference (IV, Fixed, 95% CI) -1.20 [-1.33,
-1.07]
4.6 Post-randomisation additional surgical
interventions used to control bleeding
1 240 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.01, 4.12]
4.7 Post-randomisation additional non-sur-
gical interventions used to control bleed-
ing
1 240 Risk Ratio (M-H, Fixed, 95% CI) 0.03 [0.00, 0.42]
4.8 Side effects of the intervention (e.g.
trauma, necrosis)
1   Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.8.1 Pyrexia 1 240 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
4.8.2 Allergic reaction 1 240 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
 
 
Analysis 4.1.   Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus






Test for overall effect: Not applicable





















M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours El-Menia balloon+suture Favours usual care
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Analysis 4.2.   Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal






Test for overall effect: Z = 1.29 (P = 0.20)



















M-H, Fixed, 95% CI
0.14 [0.01 , 2.74]
0.14 [0.01 , 2.74]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours El-Menia balloon+suture Favours normal care
 
 
Analysis 4.3.   Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care






Test for overall effect: Not applicable





















M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours El-Menia balloon+suture Favours usual care
 
 
Analysis 4.4.   Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal






Test for overall effect: Not applicable





















M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours El-Menia balloon+suture Favours usual care
 
 
Analysis 4.5.   Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care





Test for overall effect: Z = 18.59 (P < 0.00001)





















IV, Fixed, 95% CI
-1.20 [-1.33 , -1.07]
-1.20 [-1.33 , -1.07]
Mean Difference
IV, Fixed, 95% CI
-100 -50 0 50 100
Favours El-Menia balloon+suture Favours normal care
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Analysis 4.6.   Comparison 4: Latex balloon (air filled) tamponade + stitch and normal
care versus normal care (Intrauterine tamponade versus normal care), Outcome






Test for overall effect: Z = 1.04 (P = 0.30)



















M-H, Fixed, 95% CI
0.20 [0.01 , 4.12]
0.20 [0.01 , 4.12]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours El-Menia balloon+suture Favours normal care
 
 
Analysis 4.7.   Comparison 4: Latex balloon (air filled) tamponade + stitch and normal
care versus normal care (Intrauterine tamponade versus normal care), Outcome 7:






Test for overall effect: Z = 2.57 (P = 0.01)



















M-H, Fixed, 95% CI
0.03 [0.00 , 0.42]
0.03 [0.00 , 0.42]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours El-Menia balloon+suture Favours normal care
Footnotes
(1) The trial methods specified that all women in the control group would receive standard care as the first line treatment. However, 19/120 women in the control group subsequently received UBT as a second-line treatment. The authors preserved intention-to-treat (those 19 women remained in the control group).
 
 
Analysis 4.8.   Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care













Test for overall effect: Not applicable































M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours UBT Favours usual care
Footnotes
(1) No defintion of 'pyrexia' given in Soltan 2007
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Comparison 5.   Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus
(Intrauterine tamponade versus another mechanical/surgical method)





Statistical method Effect size
5.1 Mortality due to bleeding 1 13 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.2 Hysterectomy to control bleeding 1 13 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.3 Serious maternal morbidity (renal or respira-
tory failure, cardiac arrest or multiple organ fail-
ure)
1 13 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.4 All cause mortality 1 13 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.5 Mortality from causes other than bleeding 1 13 Risk Ratio (M-H, Fixed, 95% CI) Not estimable




5.7 Blood transfusion (red cell or whole blood) 1 13 Risk Ratio (M-H, Fixed, 95% CI) 0.57 [0.14, 2.36]
5.8 Post-randomisation additional surgical inter-
ventions used to control bleeding (arterial liga-
tion, compressive, uterine sutures, arterial em-
bolisation, laparotomy)
1 13 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
5.9 Side effects of the intervention (e.g. trauma,
necrosis)
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
5.9.1 Adverse effects requiring surgical interven-
tion
1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed
5.9.2 Fever 1   Risk Ratio (M-H, Fixed, 95% CI) Totals not select-
ed






Analysis 5.1.   Comparison 5: Bakri balloon tamponade versus haemostatic square
suturing to the lower segment of the uterus (Intrauterine tamponade versus






Test for overall effect: Not applicable
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Analysis 5.2.   Comparison 5: Bakri balloon tamponade versus haemostatic square
suturing to the lower segment of the uterus (Intrauterine tamponade versus






Test for overall effect: Not applicable
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Bakri Balloon Uterine Compress'n suture
 
 
Analysis 5.3.   Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower
segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome






Test for overall effect: Not applicable
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Analysis 5.4.   Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of






Test for overall effect: Not applicable
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Analysis 5.5.   Comparison 5: Bakri balloon tamponade versus haemostatic square
suturing to the lower segment of the uterus (Intrauterine tamponade versus another






Test for overall effect: Not applicable
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Mechanical and surgical interventions for treating primary postpartum haemorrhage (Review)









Cochrane Database of Systematic Reviews
 
 
Analysis 5.6.   Comparison 5: Bakri balloon tamponade versus haemostatic square
suturing to the lower segment of the uterus (Intrauterine tamponade versus another





Test for overall effect: Z = 4.07 (P < 0.0001)





















IV, Fixed, 95% CI
-426.00 [-631.28 , -220.72]
-426.00 [-631.28 , -220.72]
Mean Difference
IV, Fixed, 95% CI
-500 -250 0 250 500
Bakri Balloon Uterine Compress'n suture
 
 
Analysis 5.7.   Comparison 5: Bakri balloon tamponade versus haemostatic square
suturing to the lower segment of the uterus (Intrauterine tamponade versus another






Test for overall effect: Z = 0.77 (P = 0.44)



















M-H, Fixed, 95% CI
0.57 [0.14 , 2.36]
0.57 [0.14 , 2.36]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Bakri Balloon Uterine Compress'n suture
 
 
Analysis 5.8.   Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to
the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical
method), Outcome 8: Post-randomisation additional surgical interventions used to control






Test for overall effect: Not applicable
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Analysis 5.9.   Comparison 5: Bakri balloon tamponade versus haemostatic square suturing
to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/
surgical method), Outcome 9: Side eBects of the intervention (e.g. trauma, necrosis)
Study or Subgroup



















M-H, Fixed, 95% CI
Not estimable
0.17 [0.01 , 3.06]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Bakri Balloon Uterine Compress'n suture
 
 
Analysis 5.10.   Comparison 5: Bakri balloon tamponade versus haemostatic square
suturing to the lower segment of the uterus (Intrauterine tamponade versus another





Test for overall effect: Z = 6.50 (P < 0.00001)





















IV, Fixed, 95% CI
-231.00 [-300.70 , -161.30]
-231.00 [-300.70 , -161.30]
Mean Difference
IV, Fixed, 95% CI
-200 -100 0 100 200
Favours Bakri Favours uterine sutures
 
 
Comparison 6.   Bakri balloon tamponade versus condom-loaded Foley catheter (one intrauterine tamponade
technique versus another intrauterine tamponade technique)





Statistical method Effect size
6.1 Hysterectomy to control bleeding 1 66 Risk Ratio (M-H, Fixed, 95% CI) 0.50 [0.05, 5.25]
6.2 Coagulopathy as defined by trialist 1 58 Risk Ratio (M-H, Fixed, 95% CI) 0.47 [0.04, 4.87]
6.3 Blood transfusion (red cell or whole blood) 1 58 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.88, 1.06]
6.4 Post-randomisation additional surgical in-
terventions used to control bleeding (arterial
ligation, compressive, uterine sutures, arterial
embolisation, laparotomy)
1 66 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.12, 3.73]
6.5 Admission to higher level of care 1 58 Risk Ratio (M-H, Fixed, 95% CI) 0.47 [0.09, 2.35]
6.6 Side effects of the intervention 1   Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6.6.1 Fever ≥ 38ºC in first 24 hours postpartum 1 58 Risk Ratio (M-H, Fixed, 95% CI) 1.87 [0.18, 19.47]
6.6.2 Endometritis 1 66 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
6.6.3 Uterine perforation 1 66 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
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Analysis 6.1.   Comparison 6: Bakri balloon tamponade versus condom-
loaded Foley catheter (one intrauterine tamponade technique versus another






Test for overall effect: Z = 0.58 (P = 0.56)



















M-H, Fixed, 95% CI
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Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours Bakri Favours condom/Foley
 
 
Analysis 6.2.   Comparison 6: Bakri balloon tamponade versus condom-
loaded Foley catheter (one intrauterine tamponade technique versus another






Test for overall effect: Z = 0.64 (P = 0.52)



















M-H, Fixed, 95% CI
0.47 [0.04 , 4.87]
0.47 [0.04 , 4.87]
Risk Ratio
M-H, Fixed, 95% CI




Analysis 6.3.   Comparison 6: Bakri balloon tamponade versus condom-loaded
Foley catheter (one intrauterine tamponade technique versus another intrauterine






Test for overall effect: Z = 0.68 (P = 0.50)



















M-H, Fixed, 95% CI
0.97 [0.88 , 1.06]
0.97 [0.88 , 1.06]
Risk Ratio
M-H, Fixed, 95% CI
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Analysis 6.4.   Comparison 6: Bakri balloon tamponade versus condom-loaded Foley
catheter (one intrauterine tamponade technique versus another intrauterine tamponade
technique), Outcome 4: Post-randomisation additional surgical interventions used to control






Test for overall effect: Z = 0.46 (P = 0.64)



















M-H, Fixed, 95% CI
0.67 [0.12 , 3.73]
0.67 [0.12 , 3.73]
Risk Ratio
M-H, Fixed, 95% CI




Analysis 6.5.   Comparison 6: Bakri balloon tamponade versus condom-
loaded Foley catheter (one intrauterine tamponade technique versus another






Test for overall effect: Z = 0.92 (P = 0.36)
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0.47 [0.09 , 2.35]
Risk Ratio
M-H, Fixed, 95% CI
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Analysis 6.6.   Comparison 6: Bakri balloon tamponade versus condom-
loaded Foley catheter (one intrauterine tamponade technique versus another
intrauterine tamponade technique), Outcome 6: Side eBects of the intervention
Study or Subgroup




















































M-H, Fixed, 95% CI
1.87 [0.18 , 19.47]






M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours bakri Favours condom/foley
 
 
Comparison 7.   Bakri balloon + stitch versus Bakri balloon without stitch (one intrauterine tamponade versus
another intrauterine tamponade technique)





Statistical method Effect size




7.2 Post-randomisation additional surgical interventions used
to control bleeding (arterial ligation, compressive, uterine su-
tures, arterial embolisation, laparotomy)




7.3 Total blood loss >= 1000 mL (before and after randomisa-
tion, not pre-specified)
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Analysis 7.1.   Comparison 7: Bakri balloon + stitch versus Bakri balloon without stitch (one intrauterine






Test for overall effect: Z = 1.06 (P = 0.29)



















M-H, Fixed, 95% CI
0.20 [0.01 , 3.97]
0.20 [0.01 , 3.97]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours Bakri + stitch Favours Bakri
 
 
Analysis 7.2.   Comparison 7: Bakri balloon + stitch versus Bakri balloon without stitch
(one intrauterine tamponade versus another intrauterine tamponade technique),
Outcome 2: Post-randomisation additional surgical interventions used to control bleeding






Test for overall effect: Z = 0.98 (P = 0.33)



















M-H, Fixed, 95% CI
0.33 [0.04 , 2.99]
0.33 [0.04 , 2.99]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours Bakri + stitch Favours Bakri
Footnotes
(1) Both women in the control group received uterine artery ligation and internal iliac artery ligation. The woman in the interventation group received uterine artery embolization.
 
 
Analysis 7.3.   Comparison 7: Bakri balloon + stitch versus Bakri balloon without stitch (one
intrauterine tamponade versus another intrauterine tamponade technique), Outcome






Test for overall effect: Z = 0.00 (P = 1.00)



















M-H, Fixed, 95% CI
1.00 [0.93 , 1.08]
1.00 [0.93 , 1.08]
Risk Ratio
M-H, Fixed, 95% CI
0.5 0.7 1 1.5 2
Favours Bakri + stitch Favours Bakri
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Comparison 8.   Intrauterine balloon tamponade (condom catheter) versus uterovaginal packing (Intrauterine
tamponade versus another mechanical/surgical method)





Statistical method Effect size
8.1 Side effects of the intervention 1   Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
8.1.1 Fever 1 212 Risk Ratio (M-H, Fixed, 95% CI) 0.47 [0.38, 0.59]
 
 
Analysis 8.1.   Comparison 8: Intrauterine balloon tamponade (condom catheter) versus uterovaginal packing







Test for overall effect: Z = 6.61 (P < 0.00001)



















M-H, Fixed, 95% CI
0.47 [0.38 , 0.59]
0.47 [0.38 , 0.59]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours condom catheter Favours uterovaginal pack
 
 
Comparison 9.   Modified B-Lynch compression suture versus standard B-Lynch compression suture (one uterine
compression suture technique versus another uterine compression suture technique)





Statistical method Effect size
9.1 Hysterectomy to control bleed-
ing
1 160 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.11, 0.99]
9.2 Mean blood loss (mL) (trialist de-
fined)
1 160 Mean Difference (IV, Fixed, 95% CI) -244.00 [-295.25,
-192.75]
9.3 Days in hospital 1 160 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.38, 0.58]
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Analysis 9.1.   Comparison 9: Modified B-Lynch compression suture versus standard B-
Lynch compression suture (one uterine compression suture technique versus another






Test for overall effect: Z = 1.98 (P = 0.05)



















M-H, Fixed, 95% CI
0.33 [0.11 , 0.99]
0.33 [0.11 , 0.99]
Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Modified Lynch suture Classic B-Lynch
 
 
Analysis 9.2.   Comparison 9: Modified B-Lynch compression suture versus standard B-
Lynch compression suture (one uterine compression suture technique versus another





Test for overall effect: Z = 9.33 (P < 0.00001)





















IV, Fixed, 95% CI
-244.00 [-295.25 , -192.75]
-244.00 [-295.25 , -192.75]
Mean Difference
IV, Fixed, 95% CI
-200 -100 0 100 200
Modified Lynch suture Classic B-Lynch
 
 
Analysis 9.3.   Comparison 9: Modified B-Lynch compression suture versus standard
B-Lynch compression suture (one uterine compression suture technique versus





Test for overall effect: Z = 0.41 (P = 0.68)





















IV, Fixed, 95% CI
0.10 [-0.38 , 0.58]
0.10 [-0.38 , 0.58]
Mean Difference
IV, Fixed, 95% CI
-100 -50 0 50 100
Modified Lynch suture Classic B-Lynch
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